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A B S T R A C T 
The presence o£ spontaneously occurring autoantibodies 
to nuclear antigens is a hallmark of diseases collectively known 
as autoiininune diseases and include systemic lupvuB erythematosus, 
progressive systemic sclerosis, rheumatoid arthritis and Sjogren's 
syndrome, The antigens recognized in these rheximatic diseases 
include single-stranded DNA, single-stranded RNA, double-stranded 
DNA, double-stranded RNA, ribonucleoprotein, nucleosomes, histones 
and nonhistone proteins, Antibodies to DKA are of prime impoirtance 
in both human and animal diseases• The laboratory detection of 
circulating anti-DNA antibodies is of great clinical significance 
not only for the diagnosis of rheumatic diseases but also for the 
management of patients afflicted with them. A nixnnber of techniques 
have been adopted for the measurement of anti-DNA antibodies but 
their usefulness is limited by one or more factors. 
The incidence of anti-DNA antibodies in various rheximatic 
diseases was studied by inmunoprecipitation and hemagglutination 
techniques and the sensitivity of these assays was compared with 
spectrophotometric and fluorometric techniques reported in this 
thesis, Seventeen percent and 26% of SLE patients were positive 
for anti-DNA antibodies by immunodiffusion (ID) and counter-
immunoelectrophoresis (CIE; respectively as compared to 35% with 
passive h«nagglutination assay (PHAI. Antibodies to DNA were 
positive in 39% and 43% of SLE patients with spectrophotometric 
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and fluorometric techniques respectively, Anti-DNA antibodies 
were detected in 14% of SLE patients with overlapping PSS by PHA» 
spectrophotanetric as well as fluorometric techniques. However, 
none of such sera was positive by immunoprecipitation techniques. 
These results show that both spectrophotoraetric and fluorometric 
techniques are more sensitive than ID and CIS and almost parallel 
in sensitivity to PHA, 
A microplate enzyme-linked immunosorbent assay (ELISA) is 
described for the measurement of anti*-DNA antibodies. The method 
employs plastic surface for antigen binding and alkaline phos-
phatase-linked rabbit anti-human IgG for the detection of immune 
complexes, using colorigenic (PNP-P^ and fluorogenic (4MU-P) 
enzyme substrates. The sensitivity of the two substrates was 
compared in ELISA under different experimental conditions. Fifty 
seven percent of SLE patients were positive for anti-DNA antibodies 
with PNP-P and 7154 with fluorogenic substrate. Microplate ELISA 
as described in this thesis in conjunction with 'MU-P is simple, 
sensitive and could be of help in the detection of low avidity 
anti-DNA antibodies, 
The sensitivity of ELISA has been fxirther increased by 
the use of different solid support to increase the surface area 
for antigen insnobilization and by decreasing nonspecificity and 
background values. We report the successful utilization of nylon 
as solid phase for antigen binding for use in ELISA in the detec-
tion of anti-DNA antibodies. A number of preliminary experiments 
iii 
were performed to define the experimental conditions for optimum 
results. The prevalence of anti-DNA antibodies in rhetimatic 
diseases was ccxnpared using fluorogenic and colorigenic enzyme 
substrates. Fifty two percent of SLE sera were positive for 
anti-DNA antibodies with PNP-P and 56% by 4MU-P as substrates. 
Fourteen percent of SLE patients with overlapping PSS and 10% 
of PSS patients showed a positive reaction with both the substrates* 
ELISA utilizing nylon as solid support is convenient, specific 
and suitable for use in clinical laboratories where large number 
of samples are to be screened for the detection of anti-DNA 
antibodies. Antigen coated beads can be stored for appreciable 
period without loss in antigenicity. The procedxire requires 
small quantities of antigen or antibody and is therefore highly 
econcsnical. 
Anti-DNA antibodies in the sera of patients with various 
rheuonatic diseases were classified into three types depending 
upon their avidity, on the basis of their reaction in ID, CIE, 
PHA and ELISA utilizing nylon as solid phase. Twenty one percent 
SLE patients, 14% SLE PSS and 10% PSS patients showed low 
avidity anti-DNA antibodies. Twenty three percent of SLE patients 
and 14% SLE + PSS patients demonstrated moderate avidity whereas 
thirteen percent of SLE patients had high avidity anti-DNA 
antibodies. 
Rabbits immiinized with calf thymiis ds- and ssDNA-MBSA 
complex elicited antibodies against ssDNA as detected by immuno-
iv 
precipitation and hemagglutination techniques« indicating their 
specificity for bases and that the antigenic determinants are 
not related to the backbone of DNA, 
Antibodies to native DNA can not be produced by experi-
mental immxiniaation but occur spontaneously in NZB/HZW mice 
which are genetically predisposed to a disorder closely resem-
bling human SLE, We report the production of antibodies against 
DNA-psoralen adduct showing crossreactivity with dsDNA. These 
antibodies were not detectable by immunoprecipitation and hema-
gglutination techniques. ELISA utilizing nylon as solid support 
was adapted for the detection of these antibodies. The production 
of low avidity^ conformation oriented antibodies in animals 
immunized with DNA-psoralen adduct was observed. These antibodies 
were specific for DNA-psoralen adduct and showed strong cross-
reactivity with dsDNA. Single-stranded DNA and RNA exhibited low 
reactivity with immunized sera. SLE anti-DKA antibodies isolated 
by affinity chromatography using dsDNA-Sepharose 4B colximns were 
used to study the specificity of immune sera. The results showed 
that affinity purified anti-DNA antibodies have an immunological 
specificity identical to that of the e3Q)erimentally immunized sera, 
The results presented here suggest that although it is not 
possible to imm\inize animals against dsDNA but when DNA is 
intercalated with psoralen, this apparently nonirarounogenic 
molecule bec<xnes immunogenic as a result of change in some portion 
of DMA molecule induced by intercalation with psoralen. The 
low reactivity of immuniaed sera with ssDNA/RNA could probably 
be due to nonavailability of the antigenic bases to elicit 
antibody response. It is proposed that similar structxxral 
changes might occur in DNA by catisative agent(s) maXing it 
highly antigenic and thus contributing to the pathogenesis of 
SLE. 
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I. I N T R O D U C T I O N 
The ne«<i for self and nonself discrimination was appre-
ciated long ago and the concapt of autoiiranunity waa considerad 
early in the development of immunology. Autoimmunity can be 
considered as two stage process in which a breakdown of 
inanunological regulation activates immunologic effector mecha-
nism which results in autoantibody formation and tissue 
destruction. 
Immune reactions are mediated by a nxanber of different 
effector cells. These include B lymphocytes and their plasma 
cell progeny, T lymphocytes which are active in cellular 
immunity and delayed hypersensitivity, monocytes and related 
tissue macrophages. These effector cells are regulated by an 
intricate net work of controlling mechanism. Autoimmunity may 
arise not as a primary effector cell abnormality but rather as 
the consequence of disordered inmnunologic control. The mechanism 
of autoiRORiuiity is unknown. It is frequently associated with 
genetic, inmunelogic and viral factors that interact with immune 
system and influence regulation (Talal, 1976, 1978, 1981K 
The first attempt to explain how self unresponsiveness 
might be acquired was put forward by Burnet (1962) as a corollary 
to his clonal selection hypothesis. This hypothesis postulated 
that each clone of lymphocytes gives rise to cells making antibody 
of only onm specificity. H« al«o suggested that antibody diversity 
is generated by rapid somatic mutation especially in ®nbryonic 
developaent. Since some randoiaiy generated clones would necessarily 
be capable of reacting with self antigens, he surmised that these 
would be eliminated if they com® into contact with the corres-
ponding autoantigen during the critical period of development. 
Thus aJLI self reactive lyrayphocytes would be deleted and the rest 
retained. The above hypothesis for self tolerance is no longer 
tenable in its simplest form because normal animals show some 
evidence of autoiiranunity including autoantibodies, autoantigen 
binding B cells and autoantibody secreting plasma cells. These 
are found even when the autoreactive lymphocytes are known to have 
been exposed to the corresponding autoantigen from early life 
(Elson et al., 1979^. 
Hossal and Pike (1975) Revived a hypothesis which proposes 
that at some stage of their differentiation from stem cells to 
mature antibody forming prectirsor cells, B lymphocytes go through 
a phase during which contact with antigen induces only tolerance 
and not immunity. This theory is different from Burnet's (1962) 
in focussing attention on the stage of differentiation of lympho-
cytes rather than the animal as a whole. The tolerant state 
induced in differentiating cella is independent of suppressor 
cells and appears to result from the failure of mature progenitors. 
This is probably how most self teactive lymphocytes are eliminated. 
1 
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If moat autor«activtt B cells are deleted then hovr do some 
emerge tmscathed 7 Some may escape because the corresponding 
antigens are not expressed until after the B cells complete their 
differentiation or because the concentration of autoantigen is 
too low. Perhaps the critical factor governing the fate of 
immature autoreactive B cells is the avidity of antigen binding 
by their surface immunoglobulin receptors , the higher the avidity 
then the more complete the irreversible loss of receptors. 
Support for this contention comes from observations that tolerance 
in immatxure B cells is more easily induced with multivalent than 
with paucivalent hapten-protein conjugates (Metcalf and Klinmeui, 
1976; Elson, 1977) and in high avidity clones than low avidity 
1 clones (Nossal et gl,/ 1979), 
Of various autoimmune diseases, systemic lupus erythe-
matosus (SLE; is considered to be the prototype. A large varie-
ties of antibodies against nucleic acids« nucleoproteins« cell 
svurface antigens and phospholipids have been studied in this 
disease. There has been no explanation for the extensive 
diversity in the serological abnormalities of the disease. Lupus 
autoantibodies are not as diverse as they seem and are restricted 
in both their ligand-binding properties and their idiotypic 
diversity. These findings imply that the process of polyclonal 
B cell activation, the presimed final comm<»a pathway of antibody 
production in SLE must involve a restricted population of lympho-
cytes (Schwartz, 1983 
Studies of monoclonal reprasentatlvcs of the major class 
of lupus autoantibodies - antl-DNA antibodies have disclosed that 
a single autoantibody can bind to multiple nucleic acid antigens 
of widely different base ccwnposltlon (Andrzejewskl et gl., 1981/ 
Koike et 1982; Plsetsky and Caster, 1982;. Another means of 
ascertaining the nature and limits of the polyclonally activated 
population of B cells in SLE is by analysis of the idlotypes of 
lupus autoantibodies. Several such investigations have been 
carried out. These investigations strongly suggest that anti-DNA 
idlotypes originate from a restricted family of germ line genes. 
Moreover, the study reveals that the population of lymphocytes 
that can produce antl-DNA antibodies occxir not only in lupus prone 
mice but also in normal mice. The spontaneous production of such 
antibodies, therefore, must involve the loss of regulatory mecha-
nism that operates either at the level of immunological process 
or on the expression of immxinoglobulin genes (Schwartz, 1983). 
The presence of spontaneously occurring autoantibodies to 
many nuclear antigens occur in disease conditions collectively 
known as autoimmune diseases which include systemic lupus erythe-
matosus (SLS), rheumatoid arthritis (RA;, progressive systemic 
sclerosis (PSSj, Sjogren's syndrome (SSj, dermatomyosltis (DMJ, 
and mixed connective tissue disease (MCTD), Nuclear macromole-
ctiles recognized as antigens in these autoinontme diseases include 
doxible-stranded deoxyribonucleic acid (dsDNAJ, single-stranded 
deoxyribonucleic acid (SSDNA), double-stranded ribonucleic acid 
(dsRNAJ, alngle-stxanded ribonucleic acid (ssRNA^, rlbonucleo-
proteins (RNP^, deoxyrlbonucleoprotelns (DNP;, nucleosomes, histone 
and nonhistone proteins (Tan and Kunkel, 1966; Arana and Seligmann, 
1967; Matiolli and Reichlin, 197i; Stollar, 197i; Tan and Lemer, 
1972; Hannestad and Stollar, 1978; Douvas ej^  si,* 1979a; Lemer 
Si'* 1981), 
Antibodies against dsRNA and Dl^ A-RNA hybrid are £ound in 
majority of SLE patients (Schur and Monroe, 1969; Steinberg et al.# 
1969; Hiroshi, 1980). Autoantibodies against SSRNA and double-
stranded synthetic polymer like poly ItC, poly A;U (Eilat et al., 
1978), synthetic ssRNA like poly A, poly C (Koffler et al., 197i; 
Pillarisetty et §1., 1975), tRNA (Eilat et §1., 1976) and 
ribosranal RNA (Lamon and Bennet, 1970) have been well established. 
Antibodies against heterogeneous nuclear RMA have also been 
demonstrated (Ali and Tan, 1979). Autoantibodies against RNA are 
also present in the New Zealand motise, NZB/NZW Pj^  hybrid (Eilat 
et 1977). RNA antibodies show marked specificity for RNA 
and do not show any crossreactivity with native DNA. However 
crossreactivity was observed with DNA-RNA hybrids (Stollar, 1970), 
Antibodies to histones have been reported in 95 percent 
of patients with procainamide induced lupus erythematosus 
(Fritzler and Tan, 1978), 30 percent of patients with idiopathic 
SLE (Kunkel g^ si., I960; Tan e^ aJ.., 1976) and 35 percent of 
patients with rheumatoid arthritis (Aitcheson et gl., 1980). 
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These antibodies have reactivity against H^A, H^B, H^ and H^ 
histone sobpopulations (Rekvig and Hannestad, X979). It has been 
reported that the majority of drug induced lupus patients h«d 
antibodies directed against the HgA-H^B histone complex (Tan and 
Portanova* 1981 j, A n\aanber of studies have been carried out to 
determine the precise antigenic determinants on deoxyribonucleo-
protein. It has been shown that when the DNA moiety of deoxy-
ribonucleoprotein is destroyed by digestion with DNase, the 
antigen is no longer reactive with antibody. Similarly when the 
histone moiety of deoxyribonucleoprotein is digested with trypsin, 
the remaining laJA is also no longer reactive with antibody. 
Because of these and a number of other observations it was postu-
lated that the binding of antibodies to deoxyribonucleoprotein is 
dependent on the presence of both proteins and DNA but is indepen-
dent of the structural integrity of the entire deoxyribonucleo-
protein (Holman and Deicher, 1959,* Tan, 1967,* Tahourdin and 
Bustin, 1980K 
A variety of other autoantibodies against tissue extracts 
have been described in the sera of patients with SLB and other 
connective tissue diseases* Recent studies have explored the 
significance of antibodies to nuclear nonhistone (acidicJ antigen 
Sm (Tan and Kunkel, 1966;, RNP (Sharp et al,, 1972;, Ro or SS-A 
(Clark et 1^ 1., 1969), La or SS-B (Alspaugh and Tan, 1975,* Alspaugh 
et si., 1976,* Akisuki et al., 1977), RAP (Alspaugh and Tan, 1976), 
PM-1 (Reichlin and Mattioli, 1976.* Wolfe et al., 1977), Scl-70 
* 
(Douvas et 1979b; and hav« domonstrated thair diagnostic 
spacificity and association with cartain clinical faaturas in 
these diseases. Microsoroal (Deicher et al.« I960), lysosomal 
(Wiederman and Meischer, 1965), ribosoraal (Schur et al.# 1967/ 
Lamon and Bennet# 1970) and mitochondrial (Doniach et al., 1966) 
antibodies have been reported in these diseases. Recently anti-
bodies to neurons (Toh and Mackay# 1981), a-interferon (Pantm et 
gl., 1982), acetyl choline receptor (Valesini, 1983), poly ADP-
ribose (Morrow g^., 1982) and collagen (Oioud et gl,, 1982) 
have been reported in SLE« 
Antibodies to DNA is of prime importance in both the 
human and animal diseases (Koffler et §1,, 1967/ Lambert and 
Dixon, 1968,* Andres et al., 1970/ Atkins et al., 1972/ Landry and 
Sams, 1973; Tan, 1976/ Swaak et §1., 1982), The formation of 
antibodies to DNA generally occurs in SLE, New Zealand hybrid 
mice (NZB/N2W), Palmerston North mice, MRL and BXSB mice (Talal 
and Steinberg, 1974,* Walker et al.* 1978,* Sawada and Talal, 1979,* 
Kolaja and Past, 1981,* Hahn, 1982). Anti-DNA antibodies have 
been shown to be particularly injurious type of antibodies in 
terms of production of inflammatory vasculitis in the kidneys of 
patients with SLE (Tan and Kunkel, 1966). The presence of DNA 
and antibodies to DNA in circulation was the initial evidence 
which suggested that these (DNA'-anti-DNA) immune conplexes might 
be important in the kidney diseases. Renal involvsment is a 
frequent and serious feature of SLE involving approximately 75 
o o 
p«rc«nt of th« patlsnts (Tan and Kunkel, 1966; Koffler et al.« 
I97i; stollar, 1975; Steensgaard and Johansan, 1980; Yamada at §1., 
1982 K 
SLE sara contain heterogenaous populations of anti-DNA 
antibodies (Arana and Saligmann, 1967; Koffler et al., 1971). 
Although antibodies to native DNA appear to be almost diagnostic 
of SLE, antibodies to ssDNA are more wide spread (Hughes et al,, 
197i; Koffler e^ gl., 1971;. Recently antibodies specific for 
Z-DNA have been reported in SUE (Lafer et 5!,, 1983). Autoanti-
bodies to DNA occurring in both hx^ man and murine SLE sera can be 
divided into three major groups on the basis of specificity. 
(1> Anti-dsDNA antibodies reactive with only dsDNA. These 
antibodies do not react with single-stranded DNA and therefore it 
has been presumed that the reactive antigenic determinants on I»IA 
should be related to the double helix conformation. This pheno-
menon has been checked by studies of binding properties of 
hybridoma anti-ONA antibodies showing striking specificity for 
dsDNA (Arana and Saligmann, 1967; Koffler et §1., 197i; Andrze-
Jewski 198i; Ballard, 198i; Hahn, 1982). 
(2; Anti-dsDNA antibodies reactive with both ds- and ssDNA. 
This type of autoantibody is present in 50 to 70J4 of patients 
with SLE. Low concentrations of this antibody are also present 
in other rheumatological diseases. Because the antibody appears 
to recognize similar antiganic determinants present on double-
stranded and single-stranded most workers postulated that the 
antigenic determinants should consist at least in part of the 
deoxyribose phosphate backbone of DNA. The dual reactivity of 
these antibodies with both ds- and ssiaJA may be due to the fact 
that most dsDNA strands contain single-stranded nicks and most 
of the ssONA strands have helical areas. A unique feature of 
antibodies of this type is the fact that they occur spontaneously 
in SLE and other diseases but do not appear to be inraunogenic in 
experimental animals (Notman et gl.^ 1975; Samaha and Irvin# 1975/ 
Stollar and Papalian, 1980). 
(3) Anti-DNA antibodies reactive with only ssDNA. These 
antibodies recognize purine and pyrimidine bases exposed in ssDNA 
as antigenic determinants. These autoantibodies are found in 
patients with rheximatological diseases as well as nonrheumatological 
diseases such as chronic infectious processes (Stollar et gl.^ 
1962; Levine and Stollar, 1968; Alarcon-Segovia et jl., 1970; 
Lacouir et 3I,, 1973, Stollar, 1973). Antibodies to ssDNA cross 
react extensively with RNA (Levine and Stollar, 1968). 
Antibodies in autoiimtune diseases appear to belong 
primarily to the IgQ class of iirenunoglobulins. Antibodies to 
and antinuclear factors belong to both the IgM and IgG imnuno-
globulin classes. It is clear from murine and human studies that 
renal disease and disease activity in general are more closely 
related to high circulating levels of IgG anti-DNA antibodies 
than to IgM antibodies. In mica it is at th« tima whan production 
of anti-DNA switches to IgG that proteinuria and declining 
renal function begin. There has been recent report claiming that 
antibodies to native DNA in patients with SLE are primarily of 
IgG^ and I9G3 subclasses (Tan and Vaughan, 1919) « These sub-
classes of IgG are known to be associated with high complement 
fixing activity. IgG antibodies to DNA which are capable of 
fixing complement are more likely to be associated with clinically 
significant renal lesions than are nonccxnplement fixing antibodies 
(Arana and Seligmann, 1967,* Rothfield and Stoller, 1967,* Schur 
Sl*' 1972/ Sontheimer and Gilliam, 1978a«* Tan and Vaughan, 
1979; Hahn, 1982; Weinstein et al., 1983). 
Native DNA is a poor immunogen and its immunogenic form 
has not yet been identified. Chemical modifications of DNA (with 
suitable carrier) leads to the iimnunogenicity, and higher levels 
of specificity are due to such modifications of structures 
(Stollar, 1973, 1981). Normal animals have a remarkable tolerance 
to DNA and are only capable of making antibodies to ssDNA when 
complexed to methylated bovine serwn albumin and presented in 
Freund's adjuvant. With suitable protein carriers, ssDNA and 
synthetic polynucleotides can induce antibody formation in normal 
animals (Plescia at §1«, 1964, Stollar, 1973). It has been shown 
that DNA irradiated with UV light is a potent iiwnunogen and anti-
bodies formed react only with UV irradiated DNA showing no cross 
reaction with native or ssDNA (Tan, 1968; Natali and Tan, 1971). 
conflicting results (Steward et al., 1975/ Leon et al.# 1977; 
Tron and Bach, 1977/ Winfield et al., 1977," Griffiths et al., 
1978; Aarden et al., 1979J. SLE sera contained at least two 
distinct populations of anti-dsDNA antibodies. One population 
was of rather high avidity and dissociated slowly in the presence 
of excess DNA or high salt. The other population was of consi-
derably lower avidity and dissociated more rapidly under these 
conditions. The results of a double lebel dissociation kinetics 
study provided independent evidence supporting this hypothesis 
(Riley et 1980), Using dsDNA fragments of varying sizes 
(20 to 1200 bp), the heterogeneity of anti-DNA antibodies in SLE 
sera and the recognition of the secondary structure of antigen 
for specific binding was established. Competitive assays with 
mononucleotides, oligonucleotides, homopolymers and RNA-DNA hybrid 
indicated that two strands of polydeoxyribonucleotide were required 
for optimal reaction with these SLE serum antibodies (Ethel and 
Gunnel, 1980; Papalian et gl,, 1980; Stollar and Papalian, 1980), 
It has been reported that guanosine is the best nucleoside 
for inducing antibody prodxiction in BALB/c mice (stollar and 
Borel, 1976), Accumulation of guanine-cytosine enriched low 
molecular weight DNA fragments have been shown in lymphocytes of 
patients with SLE (Sano et al,, 1983), G-C rich DNA has been 
known to form \musual conformations such as triple-stranded, left-
handed (Z-DNA) and bent-DNA (Podder, 197i; Seising et al,, 1979; 
Wang et al,, 1981), If such specific structures take place in the 
antigen £ragin«nts# it is possible that antibodies are raised 
« 
against them. Two classes o£ DMA fragments have been isolated 
from DNA anti*-ONA iimnune ccsnplexes by electrophoresis. The small 
fragments averaging molecular weight 25,000 with a length of 30 
to 40 base pairs (bp> and the large fragments averaging molecular 
weight 100,000 with a length of 150 bp. The small fragment con-
tains an average of 55% G-C content and the large fragment contains 
A5% G-C content. Because average G~C content in total human DNA 
is 38%, it was concluded that the antigen is rich in G-C content 
(Sano and Morimoto, 1982). 
The hetrogeneity DNA antibody populations in human and 
mxirine SLE sera makes it difficult to study physicocheiinical 
characteristics and antigenic specificity. Therefore, the 
development of hybridcama technology by various workers represent 
a major advance and studies of monoclonal antibodies to DNA and 
other nuclear and cytoplasmic antigens are entering a new era. 
Serological methods are playing an increasingly important 
role in the diagnosis and epidemiological assessment of various 
rheumatic diseases. With the proper assay system the diagnostic 
value of antibodies to dsDNA seems to be beyond dovibt. Antibodies 
to DNA are found in high frequency in serxam of patients with 
active SLE but not in the serum of normal person and patients 
with a variety of other autoimmune diseases such as SS, RA and 
MCTD (Pincus 9% jl., 1969,* Hasselbacher and Leroy, 1974; Rochmis 
e^ al,, 1974; Aarden gt §1., 1975; Llghtfoot and Hughes, 1976; 
Ba»tlnet al., 1982; Swaak et a^,, 1982). 
A ntunber of techniques have been developed for the 
meas\ur«nent of antibodies to DHA which include complement fixation 
(Robbins et 1957)^double diffusion in agar (Seligman, 1957), 
latex particle agglutination (Christian et al., 1958), counter-
immunoelectrophoresis (Davis and Winfield, 1974), hemagglutination 
(Inami e^ §1., 1973), precipitation of radiolabelled DNA-anti-DNA 
immune complexes with ammonitim sulfate (Farr, 1958 ; Wold et al.J968 
Pincus et gl,, 1969), nitrocellulose membrane technique (Kredich 
et gl,, 1973), millipore filter assay tGfinsberg and Keiser, 1973), 
peroxidase labelled antibody test (Vladutiu, et al., 1979), test 
utilizing glass fiber filter (Lewis et gl,, 1973), polyethylene 
glycol precipitation assay (Riley et 3!,, 1979; Smeenk et §1,, 
1982), solid phase radioimmunoassay (Tan and Epstein, 1973; Smith 
et gl., 1981), immunofluorescence (Sontheimer and Gilliam, 1978b; 
Scmerfield and Wilson, 1980), fluorometric assay (Shepherd et 3I., 
1978) PIAX fluorometric assay (Beme et al., 1982) and enzyme-
linked inmunosorbent assay (Hillyer and Modeline, 1980; Labrouce 
et si., 1980; Miller et gl., 1981; Kavai et al,# 1982; Eaten 
et al,, 1983). 
The laboratory detection of circulating DNA antibodies 
is of great clinical significance not only for the diagnosis of 
SLE but also for evaluating its prognosis and efficacy of treat-
ment (Pincus et al., 1969; Feltkamp, 1975; Swaak et al., 1982). 
-.1 
Sensitive, rapid an4 economic procedures are desired for clinical 
diagnosis and effecient management of these patients. The poten-
tial usefulness of most of the techniques presently in use is 
often limited by one or more factors. These are lack of sensi-
tivity, specificity, complexity, difficulty in quantification, 
presence of serum inhibitors and length of time necessary to 
obtain results. There is a great deal of conflicting data 
concerning the clinical significance of anti-DNA antibody titer. 
These differences may be attributed in part to variations in the 
methods employed to detect anti-DNA antibodies, Different 
laboratories have iised different types of DNA as antigen and 
have used either ammonium sulfate precipitation or cellulose 
nitrate filtration to separate bound frran xinbound antigen. It 
has been shown that both of these variables, antigen and means 
of detection, can result in a significant difference in the amount 
of anti-DNA antibody measured in the same serum (Aarden et al., 
1975, 1976b). 
At present there are three widely accepted assays for the 
detection of anti-DNA antibodies, They are immunofluorescence, 
radioimmunoassay and enzyme-linked immunosorbent assay (ELISA). 
Iranunofluorescence assay now widely u8ed,«nploys the kinetoplast 
iHSiiiSS ® substrate. It is specific for dsDNA 
antibody by virtue of the fact that the circular DNA of the 
organism appears to be free of single-stranded DNA and histone 
contaminations (Simtheimer and Gilliam, 1978b;. In this assay 
Ifi 
smears of Crithldla lucillae are Incubated with sera to be tested 
followed by fluorescein labelled anti-human immunoglobulin serum. 
Fluorescence of the kinetoplast indicates the presence of anti-
bodies to dsDNA. Sera of SLE patients almost always have anti-
bodies reacting with cell nuclei i.e. antinuclear antibodies (ANA), 
therefore a nuclear fluorescence ccaamonly occurs in the Crithidia 
luciliae assay. The nuclear fluorescence is often difficult to 
differentiate from the kinetoplast fluorescence, especially when 
sera are diluted for titration purposes (Vladutiu et al., 1979), 
In practice immunofluorescence is not easy to quantify for anti-
body assays since it depends on subjective visual assessments of 
fluorescence and the results are usually expressed as the serial 
dilutions of serum that gives least fluorescence. 
The most extensively used technique for the detection of 
anti-DNA antibodies in terms of sensitivity and diagnostic 
specificity is the radioimmtinoassay (RIA)of Farr (1958;. Although 
it is a highly sensitive technique, nevertheless expensive and 
involves the use of sophisticated radioactive measuring instru-
ments which limit its use in laboratories where all these facili-
ties do not exist. Both advantages and disadvantages are derived 
from radioactive nature of its label (Schall and Tenoso, 1980). 
Farr assay has recently come under criticism for alleged inability 
to detect low avidity anti-DNA antibodies. A small percentage of 
antibody binding was not detected when this assay was performed 
under the conditions generally used. Conditions of incubation. 
buffer, pH, concentration of reactants and molecular weight of 
antigen are very important for optimal detection of anti-DNA 
antibodies by airanonium sulfate assay (Rxibbin et al., 1978^. The 
high salt concentration of the ammonixim sulfate precipitation 
dissociates all DNA/anti-DNA complexes of low avidity (Griffiths 
et al,, 1978, Aarden et al., 1979), 
The introduction of enzyme immunoassays originally 
described by Engvall and Perlmann (1971, 1972) and van Weemen 
and Schuurs (1971) has offered an alternative to the RIA, contri-
buting major improvements in reagent stability, waste handling 
and safety (Schall and Tenoso, 1980), The range of application 
of ELISA is potentially as wide as that of RIA and they may also 
reinforce or replace other serological tests such as immuno-
fluorescence. Automation has been applied effectively, although 
as with RIA, the definitive system has not been reported (Voller 
et al., 1976, Schall and Tenoso, 1980), Enzyme immunoassays 
employ antibodies or antigens conjugated to enzymes in such a way 
that the immunological and enzymatic activity of each moiety is 
maintained. These assays give objective results and are extremely 
sensitive. The evaluation of results can either be visual or be 
made with a rather simple spectrophotometer of the type found in 
most laboratories (Voller et al., 1976), ELISA has been described 
for the measurement of anti-DNA antibodies in SLE by varioxis 
workers (Miller et §1., 1981,* Kavai et al., 1962,' Eaton et al.. 
in 
1983j. 
The sensitivity of ELISA can be limited by the factors 
which include the type of solid phase used for antigen iitmobiliza-
tion and method used to monitor enzyme activity. In order to 
achieve the full potential of such assays* a number of modifica-
tions have been made. These include* the use of different 
materials as solid support to increase the surface area for 
liranobillzation of antigen* use of fluorogenic enzyme substrate 
to monitor enzyme activity and modification in the assay procedure 
and data expression. Such changes have resulted in the increased 
sensitivity* decreased nonspeclflclty and background values and 
ease in performing the techniques (Hendry and Herrmann^ 1980/ 
Schall and Tenoso* 1980** Aitkacl et al,* 1981** Labrousse et gl.* 
1982; Malvano e% al.* 1982; Ishaq and All* 1983). 
Enzyme immutnoassay utilizitig nylon for the covalent 
Immobilization of antibodies has been reported (Hendry and 
Herrmann* 1980), Treatment of nylon with HCl for limited time 
causes exposure of free amino and carboxyl groups. Such an 
activated nylon is highly reactive* since a number of macro-
molecules like DNA* RNA and proteins can be noncovalently 
adsorbed on Its surface. 
Ethidlum bromide (2* 7 dlaralno-9-phenyl-lO-ethyl 
phenanthridinlum bromide)* a catlonlc dye which Intercalates 
strongly and specifically with double helical DNAs and RNAs,ls 
widely xised In spectrofluorometrlc studies because of the stri)cing 
fluorescence enhancaaent it displays upon binding (Waring, 1965; 
LePecq and Paoletti, 1967; Oatti et al,, 1975;, It is generally 
agreed that strong fluorescence enhancement accompanies inter-
calation of the dye into the double helix conformation of the 
nucleic acid but there is also evidence for additional noninter-
% 
calative, less fluorescence enhanced sites which are prestsned to 
involve electrostatic binding (Waring, 1965; LePecq and Paoletti, 
1 9 6 7 O n e dye molecule is boxind for each 2-2.5 base pairs of 
DNA (Mandal et al,, 1980;, Ethidiian bromide (EB) has been used 
to probe dsRKA sequences within hnRNA from HeLa cells (Paoletti 
et al., 1980;, tRNA structure (UrbanXe et al., 1973), ssRNA 
(Gray and Saunders, 197i; Fetmteun et al., 1975;, circular DNA 
(Hiadson et al,, 1969), chromatin structure (Ide and Baserga, 
1976;, ribosoBial RNA (Lawrence and Daune, 1976;, synthetic DNA 
(Aktipis and Marts, 1974;, tRNA protein interactions (Rigler et 
al., 1971;, determination of molecular weight of DNA (Weissman 
et al., 1976; and in assaying conformational changes of DNA in 
DNP (Angerer and Moudrianakis, 1972;. 
When EB intercalates into a double helix, both its solvent 
environment and equilibrium conformation arc modified, and either 
one or both of these changes might be involved in the enhancement 
mechanism. It has been suggested that the fluorescence enhance-
ment is due to the immersion of EB in the hydrophobic region of 
the nucleic acid where it is protected against the aqueous solvent 
xxxv 
(LcPecq and P«olettl, 1967J. Bxxrns (1969) attributed the 
enhanccanent to a change In the conformation of EB. 
Shepherd et al./ (1978) reported EB assay for the 
quantitation of anti-dsDNA antibodies using IgO fractions of 
SLE sera* Their technique was based on the inhibition of 
fluorescence by the dye after displacement from DNA as a conse-
quence of immunoglobulin binding. Since EB intercalates only 
with double-stranded nucleic acids« only those antibodies which 
bind dsDNA should prevent Intercalation of EB, The amount of dye 
displaced is proportional to the amount of XgG bound, making 
direct linear quantitation of anti-dsDNA antibodies. 
The presence of antinuclear antibodies in the sera of 
paticmts treated with furocoximarins plxis 365 nm light (PUV-A 
photochemotherapy) indicates a disturbed immimological function 
as exemplified in various rheumatic diseases (Kubba et al.# 1981), 
The finding that PUV-A therapy is effective treatment for several 
diseases (mycosis fungoides, alopecia areata* vitiligo) has 
prompted investigators to study the influence of PUV~A on host 
immune functions (Grekin and Epstein* 1981). It is suggested 
that fxirocoumarins plus UV^ A irradiation does indeed have a 
profound effect on the imnunological system. Lymphocytes taken 
from patients treated with PUV-A had decreased phytohemaglutina-
tion induced l^A synthesis as compared to nontreated control 
(Friedman and Rogers* 1980). PUV-A may suppress immunological 
surveillance in the skin (Bridges and Strauss, 1980). In 
the response of T lymphocytes to HLA-D antigen is inhibited if 
either the stimulator or responder cells are pretreated with PUV-A, 
PUV-A has a lethal effect in on lymphocytes and monocytes, 
but not on the majority of the epidermal cells, suggesting that 
the beneficial effect of PUV-A on patients with psoriasis may be 
due to an effect on iiranxuiocompetant cells rather on the epidemis 
(Morhenn et al., 1980;. 
The furocotimarins, belong to a group of heterocyclic 
cOTipounds, formed by condensation of coxamarin and ftiran ring. 
Many natuural and synthetic furocoumarlns have been synthesised. 
Of these furocoumarlns, psoralen, 8-methoxypsoralen and 4,5,8-
trimethylpsoralen are used clinically in the treatment of vitiligo 
(Fowlks, 1959; Kaufman, I960; Scott et al., 1976). 
It is well known that two types of Interactions may 
occur between a furocoumarin and DNAI (1) formation of a molecular 
complex, in the dark, consisting of an intercalation of a 
furocoumarin molecule, in its ground state, between 2 base pairs 
of DNA, involving very weak forces such as Vender Waal's forces, 
hydrogen bonding and hydrophilic forces; (11) photochemical 
reaction, following irradiation with UVA light, leading to a 
covalent combination of furocoumarin molecule to pyrlmidlne bases 
of DNA (Dall'Acqua et al., 1979; Hearst, 198i; Sherman and 
Grosswelner, 1981), Only pyrlmidlne bases thymine, cytosine or 
22 
xiracilf their nucleosides and nucleotides react with furocovmarins 
(Musajo et al,, 1965,* Musago et 1966/ Krauch et al., 1967; 
Pathak and Kramer« 1969} • No evidence has been obtained frcsm 
chrcxnatographic or labelled radioactive tracer studies that 
furocoumarin react with purine bases* adenine or guanine and their 
nucleosides (Musajo et al., 1965), 
It has been suggested that the drugs with the ability to 
form ccxmplexes with DNA and DNP are most likely to induce the 
ANA formation (Grabar, 1974). Antibodies against histones* ssDNA, 
nuclear ribonucleoprotein are detectable in patients treated with 
procainamide and hydralazine (Stollar* 1981), So far no report 
of the occurrence of anti-dsDNA antibodies in such patients 
have appeared. 
Antinuclear antibodies have been reported in patients 
^ undergoing PUV-A therapy. However* antibodies to dsDNA have not 
been detected, although it is known that psoralen forms a 
covalent photoadduct with DNA in the presence of UVA light and 
makes it iMnunogenic (Zarebska et al,# 1978). In such studies 
Farr assay was «nployed for the detection of antibodies which is 
under criticise for its inability to detect anti-Ea?A antibodies 
of low avidity. 
The present work describes the detection and quantitation 
of anti-DNA antibodies in the sera of patients with various 
rhetamatic diseases and rabbits immunized with ds^ and ssDNA by 
22 
iRsnimopreclpitatlon and hemagglutination techniques. The 
•ensltlvlty of these techniques was compared with spectrophoto-
metrlc and fluorometrlc method which were developed In the labo-
ratory for antl-I^A antibodies. An enzyme-linked Immunosorbent 
assay (ELISAJ Is described for the assay of antl-DNA antibodies 
employing plastic surface for antigen binding. Experiments 
were performed to canpare the sensitivity of colorlgenlc and 
fluorogenlc enzyme substrates under different experimental condl-
f 
tlons. We report the successful utilization of nylon as solid 
support for antigen Immobilization for use In ELISA In the detec-
tion of antl-DNA antibodies. The production of low avidity 
antibodies against DNA-psoralen adduct showing crossreactivity 
with dsDNA have also been described. The antigenic specificity 
of affinity purified antl-DNA antibodies frcwn positive SLE serum 
was compared with the antibodies elicited by Immunization of 
animals with DNA-psoralen adduct. 
II. E X P E R I M E N T A L 
A. MATERIALS 
Bovin® serum albumin and calf thymus DNA wer« purchased 
£rom Sigma Chemical Company, U.S.A. Psoralen was a gift from 
C.D.R.I.« Lucknow. Freund's complete adjuvant was obtained 
from Difco Chemical Company, U.S.A. Methanol and magnesium 
turnings were obtained from B.D.H., India and iodine from 
E. MercH, Germany. 
Agarose, 4«tnethylumbelliferyl phosphate, 2~amino-2 
methyl-l-propanol, picarylsulfonic acid, ethidium bromide, 
alkaline phosphatase (bovine intestine, type VII-S) and goat 
anti^hunan IgG and IgM were purchased from Sigma Ch«nical 
Company, U.S.A. Calf senun was fron Microlab, India, p-nitro-
phenyl phosphate was obtained from C.S.l.R. Center for Biochemi* 
cals, Delhi, Polystyrene flat bottom plates having 96 wells 
(7 mm diameter) were purchased fr«n Cooke Microtiter Company, 
U.S.A. Mylon €€ was a product of B.D.H., England. Diphenyl-
amine and diethanolamine were from B.D.H., India. Tween-20 was 
from Koch~Light Laboratories, England and sodium azide was 
obtained from Polskie, Poland. 
DEAE-cellulose was obtained from Whatman, England. 
Sephadax G-200, Blue Dextran-2000 and cyanogen bromide activated 
Sepharose*4B were purchased from Pharmacia Fine Chemicals, Sweden. 
Acrylamide, Coomassie Brilliant Blue R and dithiothreitol were 
from Sigma Chemical Company, U.S.A. Biaacrylamide was from Reanal, 
Hungary, N,N,N'N'-tetramethylethylenediamine was purchased from 
B.D.H., England. Glycine was obtained from E. Merck, Germany. 
fisiiss-siisssissis • 
RNA (yeasti and orcinol were obtained from Sigma Chemical 
Company, U.S.A. Hydroxyapatite was obtained from Bio-Rad Labora-
tories, U.S.A. Glutaraldehyde was purchased from E. MercH, 
Germany. All other chemicals used were of analytical grade. 
Eguigmmt • 
Colorimetric reactions were monitored with a Spekol-10 
spectrocolorimeter (Veb Carl Zeiss Jena, F.R.G.) and fluorescence 
measur«nents were carried out on Aminco-Bowman spectrophotofluoro-
meter. Measur«nents of absorbance at 260 nm were made by a single 
beam spectrophotometer (Carl Zeiss Jena VSU 2<-P). 
Sera. 
Normal human sera were obtained from healthy subjects. 
Sera of patients with various rheumatic diseases were collected 
from outdoor and Indoor patient* of th« Department of Medicine, 
All India Institute of Medical Sciences, New Delhi. The samples 
were transported to the laboratory on ice-sodium chloride mixtxire. 
Patients with systemic lupus erythcunatosus, progressive systemic 
sclerosis, Sjogren's syndrome and rheumatoid arthritis had features 
meeting preliminary criteria of the American Rheumatism Association 
for these diseases (1973). 
Blood frcMn rabbits and guinea pigs was collected by heart 
puncture and sera were separated after 4 hours. All sera were 
stored in small aliquots at -20®C with 0,1 percent sodium azide 
as preservative. 
B, METHODS 
(1) 2®terroinatlon^of_^grote^^concen^ . 
Protein was estimated by the method of I#owry et al. (1951) 
using Folin-phenol reagent. 
(a) S'olin-phenol reagent 
was prepared by the procedure given by Folin and Ciocalteu (1927). 
100 gm of sodium tungstate, 25 gm sodium molybdate, 700 ml 
of distilled water, 48.2 ml of 85 percent orthophosphoric acid 
and 100 ml of hydrochloric acid were refluxed in dark for 10 
hours. 128 gm of lithium sulfate, 50 ml of distilled water and 
few drops of bromine were added to the mixture. Excess bromine 
was removed by boiling the mixture £or 15 minutes. The solution 
was cooled, diluted to one liter and filtered. The bright 
yellow reagent was protected from light by storing in amber 
colored bottle. The above reagent was diluted 4 times with 
distilled water before use. 
(b) Pregaration_,of_^alkallne_cogger_r^ 50 ml of 2 percent 
sodium carbonate solution prepared in 0,1 N sodium hydroxide 
was mixed with 1 ml of 0.5 percent copper sulfate in 1 percent 
sodium potassium tartrate. The reagent was prepared fresh 
before use. 
^^ ^ ^ ^ ^ ^^ alkaline copper reagent was mixed with 
1 ml of the protein sample. The tubes were left for 10 minutes 
at room temperature and 1 ml of diluted Polin-phenol reagent 
was added with immediate mixing and allowed to stand at room 
temperature for 30 minutes. The absorbance was read at 660 nm. 
Protein content of unknown sample was calculated from a standard 
plot constructed with bovine serum albumin. 
(2) SSterraination^^of^DNA^conc , 
DNA concentration was determined by the method of B\u:ton 
(1956) xising diphenylamine reagent. 
2 gm of diphenylamine was 
dissolved in 100 ml of boiling hexane. Approximately 0.5 gm of 
activated animal charcoal was added to the boiling mixture. The 
solution was filtered while hot and filtrate kept at 4®C till 
the crystallization was complete. The crystals were separated 
by filtration and air dried at room temperature. 
(hi PreBajation^of^^ghenj^lami^ 750 mg of recrysta-
llized diphenylamine was mixed with 50 ml of glacial acetic acid 
and 0,75 ml of concentrated sulfuric acid. The reagent was 
prepared immediately before use. 
^^ ^ SfSSS^BSS- ^^ ^ ^^ sample was mixed with one ml of IN 
perchloric acid. The tubes were incubated at 70*^ 0 for 15 minutes 
in a water bath and 0,1 ml of 54,3 mM acetaldehyde was added 
followed by 2 ml of diphenylamine reagent. The tubes were mixed 
and allowed to stand at room temperature for 16-20 hours and 
absorbance was recorded at 600 nm. The DHA concentration in 
unknown sample was determined from the standard plot, 
^ 3) 2®termination_,of__RNA_con , 
RNA was estimated by cupric ion catalysed orcinol reaction 
of Lin and Schjeide (1969;, 
^a) Crystalliaati«a^o|^orcinol, 5 gm of coiwnercial orcinol was 
dissolved in 100 ml of boiling benzene and decolorized with 1 gm 
of activated animal charcoal. The suspension was filtered while 
hot and kept at room temperature for 1 hour and then at till 
the crystallization was canplete. The crystals were separated 
by filtration and dried at room temperature. 
(b) Cugric^lon^reagent, 150 mg CUCI2.2H2O was dissolved In 100 
ml of conc«ntxated HCl, 
(c) stock_orclnol_solution. 12.5 gm of recrystallized orcinol 
was dissolved in 95 percent ethyl alcohol and the volume made 
to 25 ml. The solution was kept in dark, 
(di Orcinol reagent, 2 ml of orcinol stock solution was mixed 
with 100 ml of cupric ion reagent. The reagent wets prepgured 
fresh before use, 
^ ^ ^ ^ ^ solution and 2 ml of orcinol reagent 
were mixed and kept in boiling water bath for 35 minutes. Tubes 
were cooled and absorbance recorded at 660 nm, RNA concentra-
tion of unknown sample was calculated from a standard plot 
drawn by using yeast RNA. 
chromatography. 
Separation was done as described by Bemardi (1971^. 
(a) £hromatograghY_,o£^dsDNA. Native DNA at a concentration of 
1 mg/tnl in 0,01 M phosphate buffer^ pH 7,2 was passed through a 
5,5 cm X 1,5 cm column of hydroxyapatite. Stepwise elution was 
carried out using O.OIM - 0.3M phosphate buffer, p« 7.2. Frac-
tions of 3 ml were collected at a flow rate of 40 ml/ho\ir. DNA 
in each fraction was estimated by the method of Bxirton (1956J. 
xlv 
Oo\ibl«<-stranded ONA was foiuid to be eluted at 0.25 M phosphate 
bu££*r« pH 7.2 (Pig,l), 0,25 M fractions w«re pooled and used 
as dsDNA antigen. 
(bi Chromatograghj^^of_^ssDNA, Native DNA in 0.01 M phosphate 
buffer, 7,2 was denatured by heating for 15 minutes in boiling 
water bath. Samples were fast cooled and then passed through 
hydroxyapatite column. Denatured DNA showed chromatographic 
behavior quite different frcsn that of native DNA as it was eluted 
at 0.2 M phosphate buffer, pH 7.2 (Pig,2;. Fractions eluting at 
0,2 M phosphate buffer were used as ssDNA antigen. 
and SSDNA. 
(ai Preparation^of methylated_^bovine serum albumin. Methylated 
bovine serum albumin (MBSAj was prepared by the method of Sueoka 
and Cheng (1962^. One gm of bovine sertim albumin was dissolved 
in 100 ml of absolute methanol and 0.84 ml of 12 N HCl was added. 
The protein was readily soluble at first but precipitates as it 
becomes methylated. The reaction mixture was allowed to stand 
with occasional mixing at room temperature in the dark for at 
least a day. Thereafter, the mixture was centrifuged and the 
precipitate washed four times with methanol followed by two 
washings with anhydroiis ether. Residual ether was removed frcm 
MBSA by evaporation in air and residual acid by keeping it over 
KOH in a vacuiini desiccator. The dried MBSA was stored in a 
vacuum desiccator over KOH. 
Fig, i; Chrcsmatography of native calf thymus DNA on hydroxy-
apatite column. 
1.5 mg of DNA in 1.5 ml of 0.01 M phosphata buffer, 
pH 7,2 was loaded on a column of hydroxyapatite (5,5 
cm X 1.5 an). The column was washed with 0.01 M, 0,1 M 
and 0.2 M phosphate buffer and dsDNA eluted at 0.25 H 
phosphate buffer, pH 7.2. 
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Fig, 2: cairomatography of denatured DNA on hydroxyapatite coluamn. 
Native DNA (1 mg/inl in O.OIM phosphate buffer, pH 
7.2) was denatured by heating and applied onto a coltjinn 
of hydroxyapatite (5,5 cm x 1,5 an). Stepwise elution 
was made fran 0.01M-0,3M phosphate buffer, pH 7.2, 
Fractions of 3 ml were collected and monitored for DNA. 
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(b^ * Suitably Iffimunogenlc protein 
conjugates wer« prepared by mixing «squal volumes of DMA (1 mg/fol) 
and MBSA (O.S mg/fni). The reaction was carried out at room tem-
perattire with gentle mixing, 
(c) inmuniza^on^schedu^ Rabbits (nine to twelve months old, 
weighing 1 to 1.5 kg) were Injected intramuscularly for 3 weeks 
with freshly prepared antigen-MBSA complex containing 350 Mg of 
hapten in a total volume of 1.4 ml. A single rabbit received a 
total of 1.05 mg of hapten in the course of three injections, 
Antisera were separated frcxn blood obtained by cardiac ptmcture 
7 to 10 days following the last injection, 
(6) • 
Serum IgG was isolated by DEAE-cellulose adsorption method 
of Stanworth (1960i, IgG was also isolated by DEAE-cellulose 
chromatography of the crude immtinoglobulin precipitate obtained 
by 4054 ammonium stilfate saturation of senan. 
Approxi-
mately 17 gro of moist D£A£»cellulose previously washed and 
equilibrated with 0,01 M sodium phosphate buffer containing 0,015 M 
NaCl, pH 7.5 was mixed with 2,5 ml of cold phosphate buffer. 2,5 
ml of serum (previously dialyzed for 16 hours at against 
phosphate buffer^ was added dropwise to the exchanger with conti-
nuous mixing. The mixture was kept for 5 hours at 
Thereafter 5 ml of cold buffer wae added with stirring. The 
resulting slurry was centrlfuged in cold for 15-20 minutes. The 
supernatant was removed and cleared of cellulose, if any, by 
recentrifugation. The pxirity of the isolated IgQ was checked on 
Sephadex G-200 column (54,6 on x 1,8 cm) using 0,1 M phosphate 
buffer, pH 6,5 as eluent and by polyacrylamide gel electrophoresis 
using 10 percent gel. The protein was found to be essentially 
homogeneous, 
(b) SSggaration^of^crude^imm^ 4 ml of 100 percent 
satxirated ananonium sulfate solution was slowly added to 6 ml of 
serum in cold and the mixtvire was left at 4®C for 1 hour for 
complete precipitation of the immunoglobulins. The precipitate 
was recovered by centrifugation and washed thrice with 40 percent 
saturated aRBnonium sulfate solution. The washed precipitate was 
dissolved in and dialyzed against 10 nM jdiosphate buffer, pH 8.0, 
(c) • Dialyzed crude immunoglobulins 
were loaded onto a coltimn of DEAE-cellulose (20 cm x 2 am) pre-
viously equilibrated with the starting buffer (10 mM phosphate 
buffer, pH 8,0), The column was eluted at room temperature with 
linear ionic strength gradient of lOmM - 300e^ phosphate buffer, 
pH 8,0, 3 ml fractions were collected and monitored for protein 
(Fig.3), First peak of the chrotnatogram was pooled and used as 
purified IgG. The material was homogeneous and gave a single band 
in polyacrylamide gel electrophoresis. 
Fig, 3t Fractionation of serum iramunoglobulins by DEAE-cellulose 
chrcanatography. 
40^ saturated ammonitim sulphate precipitated serum 
fraction was dissolved and dialyzed against 10 mM phos-
phate buffer, pH 8.0 and loaded on a column of DEAE-
cellulose (20 cm X 2 cm). The elution was performed by 
applying linear ionic strength gradient of 10 mM - 300 mM 
phosphate buffer, pH 8,0. Fractions of 3 ml were 




Sheared DNA was used as antigen in immunodiffusion, 
counteriinmunoelectrophoresis and passive hemagglutination 
techniques for the meastxrement of anti-DNA antibodies. It was 
prepared by passing 1 rog/nl dsDNA in PBS (0,01 M phosphate buffer 
in oaSM Nad, pH 7.2) or Mcllvaine buffer (0.05 M citric acid, 
O.IM NajHPO^, pH 4,9; three times through a sterilized 21-gauge 
needle. Single-stranded DNA was prepared by heat denaturation. 
(a; SffiSHSS^flUSiSS• precipitin reactions were carried out 
by Ouchterlony double diffusion using glass petri dishes as 
described by Seligmann (1957) and Tan et al. (1966K 6 ml of 
molten, filtered, 0,4 percent agarose in PBS containing 0,1 per-
cent sodium azide was poxired i n S c m x l . S c m glass petri dishes 
and allowed to harden at room t^perature. The petri dishes were 
stored at 4^C. All the sera tested were decomplemented by heating 
at 56°C for 30 minutes. 50 Ml of each serum and antigen was 
placed in the wells and the reaction was allowed to proceed for 
2-4 days in a moist chamber at room temperature. Petri dishes 
were washed with 5 percent sodium citrate for 4 hours to remove 
nonspecific precipitin lines. The precipitin lines were analysed 
visually and the results recorded. 
(bjl * Counterimmunoelectrophoresis 
(CI£j was performed as described by Davis and Winfield (1974;. 
-Ti rj 
f 
3 ml of 0.6 percent molten agarose prepared in 25 mM 
barbital buffer* pH 8.4 containing 0,1 percent sodium azlde« was 
pipetted onto alcohol cleaned microscopic slides (2.5 cm x 7.5 cm) 
and allowed to solidify at room temperature. The slides were 
stored in a moist chamber at 4 mm wells were cut on the 
slide at a distance of 5 mm between the two opposite wells. 
Antigen was placed in the cathodal well and decomplemented serum 
in the anodal well (25 juil in each well). Electrophoresis was 
performed in 50 nM barbital buffer, 8.4 with a current of 3-4 mA 
per slide. Electrophoresis was performed for 30-50 minutes. 
Nonspecific precipitin lines were abolished by washing the slides 
with 5 percent sodium citrate for 2-4 hours. Finally the slides 
were examined for precipitin lines and the results recorded. 
(c) Microhemagglutination 
test of Inami et gl. (1973) with slight modifications was \ised 
for the detection of anti-DNA antibodies in the sera of patients 
witii various rheumatic diseases and animals inonunized with dsDNA, 
ssDNA and DNA-psoralen adduct. Sheared DNA was used as the 
source of antigen and fozmalinized sheep erythrocytes were 
employed as their passive carriers. Sheep erythrocytes were 
foxmalinized according to the procedure of Inami and associates 
(1973). 
To 0.3 ml of packed cells« 4.2 ml of 0.005 percent tannic 
acid in PBS was added. The resulting suspension was incubated 
o 
«t 37°C for 45 minutes with occasional shaking. The cells so 
treated were washed 4 tiroes with 20 Yolunes of PBS. The fifth 
and final wash was carried out with Mcllvalne buffer (citric acid 
O.OSM, NajHPO^ O.lM, pH A,9). Formallnlzed tanned cells were 
coated with dsDNA, ssDNA and DNA-psoralen adduct. DNA (50 Mg/inlJ 
In Mcllvalne buffer was added to the packed cells to give 4 
percent suspension, Mlxtiire was Incxibated at 37®C for 1 hour with 
frequent shaking. The cells were packed and washed 4 times with 
PBS and resuspended In PBS containing 0,07 percent BSA to a final 
concentration of 2,5^, The antigen coated cells were stored at 
4®C and then used wl-ttiln a week. 
All decoraplemented sera tested were adsorbed for 30 minutes 
at room temperattxre with equal volumes of fresh packed sheep 
erythrocytes that had been washed 4 times with PBS, This was 
done to get rid of heterophlllc antibodies that would otherwise 
nonspeclflcally agglutinate the antigen coated erythrocytes, 
(i; Check of sgeclflclty^^by In^^ The specificity 
of hemagglutination reaction was checked by Inhibition experiments, 
In a parallel row of wells, 50 Ml of ds- or SSDHA (100 t^g/kl in 
PBS containing 0,2 percent bovine serum albumin; was placed in 
all but the first well. To the first well were added 50 Ml of 
ds> or SSDNA at a concentration of 200 Mg/inl in PBS and 50 Ml of 
test servim, the solutions were mixed and serially diluted in 
subsequent wells containing constant level of antigen. The plates 
were shaken and inc\A>ated at 37®C for one hour and at 4®C for 
16 hours, 25 Ml of ds- or ssOHA coated cells were added to each 
well, mixed and read after 2 hours. Decrease in the hemaggluti-
nation titer compared to test without added DNA confirmed the 
presence of anti-DNA antibodies in the test serum. 
li'i 
(6) SpectrwhotOTietric assay for the detection of anti~DNA 
ant^odies. 
A spectrophotoraetric procedure utilizing purified calf 
thymus DNA as antigen was developed and carried out as follows. 
£E2SSSHES* ^ ^^ ^^ ssDNA (purified by hydroxy apatite 
column^ in 0.9 ml of 0.15 M borate sodium chloride buffer, pH 8*0 
was mixed with 0.1 ml of decomplemented serum. The mixture was 
incvibated at 37°C for 1 hoiir followed by 16-24 hours incubation 
at One ml of saturated ammonium sulfate solution was added 
and the contents mixed thoroughly. The mixture was kept for 1 
hour at for the complete precipitation of immune complexes. 
The contents were centrifuged and supernatant separated. Absor-
bance of the supernatant was recorded at 260 nm. Bach test servnt 
was r\m along with a control which contained all reagents except 
the antigen. The results were expressed in terms of percent DNA 
boxind to anti-DNA antibodies, calculated according to the formula: 
Percent DNA bound « 100 - \est ' Control X 100 A 50 Mg of DNA 
assa^. The specificity of anti-DNA antibody measurement by 
spectrophotometric assay was studied by an inhibition experiment. 
Varying concentrations of DNA were mixed with 0.1 ml of anti-DNA 
antibody positive SLE serum to a final concentration of 2 to 
50 Mg DNA/fal and incubated at 37°C for one hour and at 4°C for 
16 hours. Incubated contents were used in the assay instead of 
serum. 
bromide as intercalating dye. 
2iH2ES2£2SSS-S2§5!i£SS2Si• excitation and emission spectra 
of ethidium bromide (EB), DNA and EB-DNA complexes were obtained 
by plotting fluorescence intensity (PXjl versus wavelength. The 
excitation and eanission wavelengths were 300 nm and 590 nm 
respectively, 
(b> P£i2cigle^of_the_fluoranet^ EB forms a fluorescent 
complex with double-stranded DNA which shows strikingly enhanced 
fluorescence intensity as ccxnpared to free DNA and EB. The 
increase in fluorescence is a function of DNA concentration 
(Fig,4>. The method described measures the amoiaat of DNA bound 
in the immune complexes by the enhanced fluorescence due to dye 
intercalation. The fluorescence Intensity is proportional to the 
amount of DNA which in turn is dependent on the concentration of 
the anti-DNA antibodies. 
Pig. 4: Emission spectra of EB, DNA and EB-DNA complex. 
Insett Fluorescence intensity of EB-DNA complex as a 
fimction of DNA concentrations. 
Emission spectra were recorded with excitation 
wavelength of 300 nm. Concentration of DNA in EB-DNA 
complex: 2 Mg ( - # - ^ 4 Mg (-«- ), 6 Mg ( ), 
8 Mg (-O- >4 10 Mg >, free EB ( 10 Mg of free 
DNA ( ), The concentration of EB was kept constant 
(5 M G > L ) . 
4 
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(c) P£2cedure^of^the^fluor]^etric 10 Mg of hydroxyapatite 
pxirified dsDNA in 0.5 ml of borate buffer (0,15 M borate-sodlum 
chloride buffer^ pH 8,o; was mixed with 0.5 ml of decoinplemented 
serum in siliconized plastic txabes. All the sera were tested at 
a dilution of 115, The mixture was inciibated at 37°C for one 
hoxir and at 4°C for 20 hours, One ml of sattirated ammonium 
sulfate solution was added and the resulting fifty percent satura-
ted mixture was held at 4°C for one hoxir for complete precipita-
tion of immxme complexes. The precipitated immune complexes were 
separated by centrifugation (12,000 rpm for 15 minutes at 
and dissolved in 4.5 ml of borate buffer at 4°c. 25 Mg of EB in 
0.5 ml of borate buffer was added and fluorescence intensity 
recorded. Each test serxjm was r\in along with a control which 
contained all reagents except antigen. The fluorescence reading 
of the control was substracted from the test and the results were 
expressed in teims of percent ONA botind in the immune complexes. 
The amount of DNA bound to the iirantme conplexes was calculated 
froBi a standard plot of fluorescence intensity of EB-DNA cc*n-
plexes as a function of DNA concentration. 
(d) specificity of the assay was 
checked by performing an inhibition experiment as described 
previously in the spectrophotametric assay. 
{10; EnajTOe~linked__iromun 
(a) Buffers and other reagen^. 
(i> Bicarbonate^buffer* 15 mM sodium carbonate, 35 mM sodixsn 
bicarbonate, pH adjusted to 9,6. Sodium azlde (0.02%) was added 
as preservative, 
(ii) Phosghate^buffered saline-Tween_^PBS-T}, 136 mM sodium 
chloride, 2 mM potassium dihydrogen orthophosphate, 8 mM disodixim 
hydrogen phosphate, 0,5 ml Tween-20/lit, jdi adjusted to 7.4, 
(iiiJ Diethanolamine_buffer, 1 M diethanolamine containing 100 mg/ 
lit MgCl^.eHjO, pH adjusted to 9.8 with hydrochloric acid. 0.02 
percent sodium azide was added as preservative, 
(iv) 2-^ino-2_^me^yl-l-grogan^ ISOroM AMP, 3roM 
MgCl2# 0.1 ml Triton x-lOO/lit, adjusted to 10.3. The solution 
was filtered before use. 
(v) Substrates. 5 x lO^^M p-nitrophenyl phosphate in diethanol-
amine buffer and 1 x lo''^ M 4~methylurabelliferyl {^osphate (4MU-P) 
in AMP buffer. 
(b) P£«£S£ation^of^rabbit_anti-hw 
conjugate. Rabbits were immunized with four^weekly intra-
mtiscular injections of pturified normal htiman IgG in PBS with equal 
volume of Preund's complete adjuvant. Each rabbit received 4 mg 
IgG per injection. The animals were bled a week after 4th 
injection and IgG was isolated by DEAE-cellulose chrcanatography 
from the pooled sera, 
2 mg of isolated rabbit anti-human IgG in 0,1 ml of PBS 
was mixed with 5 mg of alkaline phosphatase. The mixture was 
dialyzed for 20 hours against PBS at 4°C with 3 changes of buffer. 
2S% glutaraldehyde was added to a final concentration of 0,2%, 
The resulting mixture was kept at room temperature for 2 hours 
and then dialysed at 4°C for 16 hours against PBS with 3 changes 
of buffer. Dialysis sack containing the conjugate was trans-
ferred to 0.05M Tris buffer pH 8.0 and dialyzed for 16 hoixrs at 
4®C. Finally the dialysis sack contents (conjugate) were diluted 
to 4 ml with Tris buffer containing 1% BSA and 0,02% sodium 
azide• 
The conjugate was partially purified by gel filtration on 
58 cm x 1,9 cm column of Sephadex G-200 in 0,1M phosphate buffer, 
pH 7.2 and the active fractions were pooled and stored at 4°C. 
(c) ELISA_grocedure. Technique of Voller et al. (1976; with 
slight modification was used for the detection and quantitation 
of anti-DNA antibodies. DNA in coating buffer (12.5 Mg/t).25 ml 
in 0.05 M bicarbonate buffer, pH 9,6; was added to the wells of 
the microtiter plate which was then incubated at 4°C for 16 hours 
The wells were washed three times with PBS-T and xmoccupied sites 
were saturated with fetal calf seriim (1% v A in PBS-T) by incu-
bation at 37®C for 1 hour. After washing the plate with PBS-T, 
0,25 ml of serum (lUOO; or IgO (lUOO at 12 n»g/ni; was added 
and the plate was incubated at 37°C for one hoxir, 0.25 ml of 
rabbit antihuman IgG alkaline phosphatase conjugate was added, 
after washing the excess antibody. The plate was once again 
incxibated at for 2 hours. At the end of incubation period, 
the plate was emptied and washed. 0.20 ml of substrate (PNP-P, 
Sxlo'^M in diethanolamine buffer, pH 9,8 or 4MU-P, Ixlo'^M in 
AMP buffer, containing 1.5xlo"^M Mg'*"'' pH 10.3J was pipetted into 
each well. The plate was incubated at 37®C for one hour and 
the reaction was stopped by the addition of 0,05 ml of 3N NaOH, 
The contents of each well were either read at 400 nm or fluoro-
metric measurements were made, depending upon the substrate. 
Excitation and emission wavelengths were 365 nm and 455 nm 
respectively. 
(11) ELISA_^with^nylon_as^solid^ghas , 
A highly sensitive enzyme-linked inmunosorbent assay was 
developed for the detection and quantitation of anti-DNA anti-
bodies in the sera of patients with various rheumatic diseases 
and animals iiranunized with ONA-psoralen adduct, using nylon as 
solid support for antigen immobilization. 
(a> Actiyation_of_^n3flon^ Nylon beads (3rmn x 2mm; were treated 
with 3.5N HCl for 36 hours at 37°C with occasional shaking and 
thereafter washed thoroughly with distilled water till free of 
acid. The exposed amino groups were detected by the treatment 
of activated beads with picrylsulfonic acid (Synder and 
Soborinski, 1975;. 
^^ ^^  EE2SS5!J£2* Activated nylon beads were treated with DNA (100 
Mg/foi; in Mcllvaine buffer (citric acid O.OSM, NajHPO^ O.IM, 
pH 5; for 24 hours at 4°C with occasional shaking. The antigen 
coated beads were washed 4 times with ST-20 (O.ISM NaCl, 0.0556 
Tween-20) to remove the unreacted DNA. Unoccupied sites were 
saturated with 1% BSA in ST-20 by keeping the beads immersed in 
the BSA solution for 12 hours at 4°c. The beads were washed 4 
times with ST-20, dried on Whatman filter paper and stored at 
-20°C until use. Activated beads treated with BSA, without prior 
antigen treatment, were \ised as control. Six beads were used 
for ELISA. All the sera were tested at a dilution of lUOO. 
Beads (test and ccmtrol) In siliconized glass tubes were incubated 
with 0.5 ml of serum for 1 hour at 37®C with occasional shaking. 
The beads were washed 4 times with ST-20 and Incubated with 0.5 
ml of conjugate (ITIOOO dilution or 11 jug/lnl protein J for 2 hours 
at 37°C. Unreacted conjugate was washed four times with ST-20. 
The final washing was done by distilled water. The beads were 
dried on Whatman filter paper and transferred to a clean tube 
containing 1 ml of substrate (PNP-P or 4MU-P;. The tubes were 
incubated at 37°C, for 3® minutes with occasional shaking. The 
reaction was stopped with 1 ml of 3N NaOH for PNP-P and 1 ml of 
IM K^HPO^-KOH buffer, pH 10.4 for 4MU-P. The absorbance (A) was 
monitored at 420 nm. Excitation and anission wavelengths were 
365 nm and 455 nm respectively. Results were expressed as 
/^^ •^ test - ^^-^control-
(c) Inhibition ELISA. The specificity of antigen-antibody 
reaction in ELISA was checked by inhibition experiments. Varying 
concentrations of DNA were mixed with an anti-DNA positive SLE 
serum to a final concentration of 2 to 20 Mg DNA/fel, The mixture 
was incubated at 37°C for 1 hour and then at 4®C for 20 hours 
and used in ELISA instead of serum. 
(12) Pfo^uction^of_^anti-pNA^antibo^es 
(aJ foration of inter-
strand cross-linkages by photoreaction of psoralen with dsONA 
was studied by column chromatography on hydroxyapatite. The 
renaturation capacity shown by drug intercalated DNA after heat 
denattiration was the basis of adduct formation (Lawley and 
Brookes, 1967K 
1 mg of hydroxyapatite ptirified dsDNA in TNE (O.OOIM Tris, 
0.015M NaCl, 2x10""^ EDTA, pH 7.5; buffer was thoroughly mixed 
with 100 Mg of psoralen in the same buffer at 25^C for one hour. 
The mixture was irradiated at a do»e rate of 2x10 ergs caro" 
min"*^  for 30 minutes using Illuminating wavelength of 365 nm. 
Samples of ONA and psoralen without irradiation were the e^eri-
mental control. Both samples were dialyzed against PBS to 
remove \inbound psoralen, Dialyzed contents were heated for 10 
minutes in a boiling water bath and then immersed in ice-®odi\am 
chloride mixture for 15 minutes. Each sample was chromatographed 
on a column (5,5 cm x 1,5 an; of hydroxyapatite, Stepwise elution 
was carried out using 0,01M - 0,3M phosphate buffer, pH 7,4, 
Fractions of 3 ml were collected at a flow rate of 40 ml/hour, 
DNA in each fraction was estimated with diphenylamine reagent. 
Fractions eluting at 0,25M phosphate buffer (cross-linkedJ were 
pooled, dialyzed against PBS and used as DNA-psoralen antigen 
for eliciting antibodies in guinea pigs, 
(b) Eguilibrii^^dlalysi The amount of psoralen intercalated 
with DNA was evaluated by equilibrium dialysis measurements as 
described by Romeu et §1, (1976), 
Dialysis bags with 4 ml of DNA-psoralen adduct were 
inwsersed in 60 ml ©f TNE buffer in stoppered round bottom flask. 
Equilibrium was allowed to attain by shaking the flask for 30 
hours at 4®c, The fluorescence intensity of the dialysate was 
recorded at 450 nm (320 nm excitationj, The concentration of 
psoralen dialyzed out was quantitated with the help of a standard 
plot obtained by drawing fluorescence intensity of irradiated 
HI] 
psoralen as a ftinction of its concentration. The amount of 
psoralen thus intercalated with DNA was determined. 
(cP • DNA->psoralen~MBSA complex was prepared as 
described previously £or ONA-MBSA. Guinea pigs (6 to 8 months 
old, weighing 400 to 500 gm) were injected intramuscularly in 
the hind limbs with the complex (2 ml) weekly for seven weeks. 
A single animal received a total of about 1.5 mg intercalated 
DNA in the course of seven injections. Serian was separated from 
blood obtained by cardiac puncture 7 days after the last 
injection. 
(d) 5®action__of^DNA-gsoralen_^i^ 
• Preimmunized and 
ONA-psoralen invnunized guinea pig sera at different dilutions 
were tested by ELISA for the reaction against adduct, dsDNA, 
ssDNA and RNA using goat anti-guinea pig IgG alkaline phosphatase 
conjugate (prepared as for rabbit anti-human IgG alkaline 
phosphatase conjugate). 
Activated nylon beads were treated with DNA-psoralen 
adduct, dsDNA, ssDNA and RNA (100 Mg/inl> in Mcllvaine buffer. 
pH 5 for 24 hours at with occasional shaking. Remaining 
steps were as described earlier. Sera were tested at a dilution 
of i:iOO in siliconized glass tubes with antigen sensitized and 
control beads. Iionune complex attached to nylon beads was 
tv 
detected by inc\ibatlng the beads in 0.5 ml of goat anti-g\ilnea 
pig IgG alkaline phosphatase conjugate (11500 dilution or 28 Mg/ 
ml proteinj. 
{13) I s o l a t i o n ^ a n d ^ g u r i f i c a t i o n _ o f , 
(a> DNA was coupled with 
CNBr activated Sepharo»e-4B according to the method for Amdt-
Jovin et gl. (1975). 
1 gm of CNBr activated Sepharose~4B was swollen in 20 ml 
of ImM HCl for 15 minutes. The gel was transferred onto sintered 
glass filter and washed with ImM HCl, ICknM potassium phosphate 
buffer, pH 8,0, The contents were transferred to a stoppered 
cylinder containing hydroxyapatite purified double-stranded DNA 
(500 juig/inl> in 50 ml of 10 mM potassium i^osphate buffer, pH 8.0 
(coupling buffer^, The mixture was rotated end-over-end for 2 
hours at room temperature and then kept at 4^C for 12 hours. 
The DNA-Sepharose product was washed on a sintered funnel with 
10 mM potassium phosphate, pi 8,0 followed by IM potassium 
phosphate, pH 8.0 and IM KCl. The gel was then washed with 0.2 M 
glycine, 8,0 and transferred to a stoppered cylinder containing 
20 ml of 0.2 M glycine. The contents were mixed end-over-end for 
2 hours at roan temperature and filtered. The gel was then washed 
with coupling buffer and finally equilibrated with TEDO buffer 
J j«. 
(50rtM Trls, O.lmM EDTA, O.lraM dlthlothreltol and 5% glycerol, 
pH 1,9), The gel was stored at 4®C. 
IgG was Isolated from an antl-DNA positive SLE serum by DEAE-
cellulose adsorption method and dlalyzed against equilibrating 
buffer at 4°C for 24 hours with 3 changes of buffer. The dialyzed 
contents were applied to affinity column (7 cm x 2 anK The 
column was washed with equilibrating buffer followed by 50mM 
Tris, O.lmM EDTA, O.lmM dithiothreitol, 5% glycerol and O.IM 
NaCl buffer, pH 7,9, Bound protein was eluted with IM NaCl in 
TEDG buffer. The eluate was dialyzed at room temperature against 
O.OlM phosphate buffer containing 0.015M NaCl, jgH 7,5 and 
concentrated, 
(c) Rjaction^of^affinitjf^g^ifle 
®P«<2ificity and crossreactivity 
of the affinity purified material was checked by CIE and ELISA. 
ELISA was carried out at various antibody dilutions (120 
Mg/fel to 0.06 Hg/ail) employing DNA-psoralen adduct, dsDNA, ssDNA 
and RNA sensitized nylon beads, Rest of the steps were as 
described previoi»ly, 
(d> 2®222»tration^of_^IgG^2M^resgons Cxrude immunoglobulins were 
isolated from an anti-DNA positive SLE servim by 40 percent satu-
rated ammonium sulfate solution. The precipitate was dissolved 
in and dialyzed against equilibrating buffer. 
Dialyzed contents were applied on affinity column and 
bound protein was eluted as described previously. IgG/lgM 
response in purified material was checked by ELISA using goat 
antl-hVBnan XgG alkaline phosphatase (i;iOOO dilution) and goat 
antl-hianan Ig^ l alkaline phosphatase (IJIOOO dilution) conjugate 
employing dsDNA coated beads. 
TQ 
-.J 
III. R E S U L T S 
(1) DeterminatlOT^^of^grecigltat^ 
dka. 
Sera of patients with SLE, PSS, SUE with overlapping PSS, 
SS^ RA and rabbits Immunized with ds-* and ssDNA-MBSA complex 
were monitored for the presence of precipitating and hemagglutl-
natlng antl-DNA antibodies by Immunodiffusion« counterlmmuno-
electrophoresls and passive hemagglutination techniques. 
Circulating antibodies against dsDNA were found In 14 and 
23 percent of patients with SLE by Immunodiffusion (IDJ and 
counterlimunoelectrophoresls (CIE) respectively. Antibodies to 
ssDMA were positive In 19 percent of SLE patients when detected 
by ID and 30 percent with CIE. Normal himan sera (NHS) and sera 
of patients with SLE overlapping with PSS, P8S, SS and RA were 
negative for precipitating antl-DNA antibodies by ID and CIE 
(Table i;. 
Rabbits Immunized with calf thymus ds- and ssDNA complexed 
to MBSA responded by educing antibodies against ssDNA. 14 and 
56 percent of dsDNA Immunized rabbits elicited antibodies against 
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percent of ssDNA liorawniaed sera were positive for antl-ssDNA 
antibodies. No reactivity was observed with dsDNA In either 
o£ the Insnunlzed animals, Antl*>dsDNA and antl-ssDNA antibodies 
were absent In the sera of prelimnunlsed animals (Table Ij. 
The Incidence and titer of antl-DNA antibodies In rheiana-
tlc diseases and rabbits Immunized with ds«> and ssDNA were also 
studied by passive hemagglutination (PHA) technique using ds-
and SSDNA coated sheep erythrocytes. Thirty five and 51 
percent of SLE sera were found positive with ds- and ssDNA 
respectively. Sera positive against dsDNA also reacted with 
SSDNA with varying degree of crossreactlvlty. The titer of 
agglutination reaction of antibody positive SLE sera ranged from 
1:8-1:512 with dsDNA and i:i6 to i:i024 with ssDNA. One out of 
seven SLE patients with overlapping PSS was positive with a titer 
of i:i6 and i:32 with ds- and ssDNA respectively. Sera of patients 
with PSS, SS, RA were negative for antl-DNA antibodies. Normal 
human sera had a titer of 0-1:8 with either of the antigen 
(Table 2;. 
Immunization of rabbits with ssDNA<-MBSA complex along 
with Freund's con^lete adjxivant produced antibodies reacting 
only with ssDNA having a titer of i:i28-i:512. Rabbits Immunized 
with dsDNA-MBSA complex elicited antibodies against ssDNA. The 
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c«lls. Very low r««ctivlty was obaenred with dsDNA (i:4-i:i6;, 
Prelmmunized rabbit sara showed a titer not exceeding ItS and 
1:4 with SB- and dsDNA respectively (Table 2), 
The specificity of agglutination reactions was checked 
by hemagglutination inhibition studies. Inhibition experiments 
were carried out with three anti-DMA positive SLE sera, two 
dsDNA imrounized rabbit sera and one ssDNA inanunized rabbit sera, 
employing ds- and ssDNA coated sheep erythrocytes. A signifi-
cant decrease in the titer of the hemagglutination reaction was 
observed in the presence of 5 Mg of DNA (Table 3 K 
(2) Sgecteoghotwe^ic^assaj^^f 
In order to have an alternative method to ID, CIE and 
PHA, we developed a spectrophotometric technique for the detec-
tion and quantitation of aati-DNA antibodies• In spectrophoto-
metric method DNA in the supernatant after precipitation of 
imiinc complexes with ammoniwi sulfate, was conveniently estima-
ted by recording the absorbance (A) at 260 nm. Results were 
expressed in texns of percent DNA bound to immune complexes 
calculated according to the formula: 
Percent DNA bound 100 - \est " control X 100 ^50 Mg DNA 
NHS and sera of patients with rheumatic diseases were 
r o 
TABLE 3 
Inhibition o£ agglutination of SLE sera and sera of rabbits 
iiamunizad with ds- and ssDNA. 
Sera (patients/ Uninhibited titer Titer after inhibition 































Agglutination inhibition was performed in the presence of 5 Mg 
of DNA. MK, JS and FG represent three different positive SLE 
sera. IRj^  and IR^ are two rabbits immunized with dsONA whereas 
IR^ is the SSDNA immunized rabbit. 
tested with dsDNA (hydroxyapatite purified^ as antigen for the 
presence of antl-DHA antibodies (Fig.5). Sera showing DNA 
binding activity of more than 30 percent were considered as 
positive. With this criteria 37 percent of SLE patients were 
positive for antl-DNA antibodies. The range of percent DNA 
binding activity of these sera was 35 to 93# depending upon the 
severity of the disease. Three patients with inactive SLE had 
DNA binding activity of 3S to 43 percent. NHS and sera of 
patients with RA, SS« PSS were all negative. One out of seven 
SLE patients with overlapping PSS showed a binding of 38 percent. 
The specificity of antigen-antibody reaction in the assay 
was studied by inhibition experiment. Percent inhibition 
obtained at different DNA concentrations, using an antl-DNA 
positive SLE sertim is shown in Fig. 6. High degree of speci-
ficity is evident since 70 percent inhibition was achieved with 
20 Mg of DNA. Besides being specific* the assay described is 
highly reproducible. Table 4 shows the intra- and inter-assay 
coefficient of variations for these measurements. 
We studied the detection and quantitation of antl-DNA 
antibodies in the sera of patients with various autolnmune 
diseases by exploiting the fact that ethidium bromide (EB; and 
dsDNA form fluorescent complex which has strikingly enhanced 
Fig, 5; Levels of DNA binding activity in patients with 
rheumatic diseases. 
The mean DNA binding values o£ positive SLE sera/ 
NHS and sera o£ patients with other rheumatic diseases 
with standard deviations are indicated at the bottom of 
the figxire. 
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Pig. 6! Danonstratlon of specificity of spectrophotcanetric assay 
by inhibition experiment. 
Varying concentrations of DNA (2 to 50 Mg/inl) were 
mixed with 0.1 ml of an anti-DNA positive SLE senan. 
The mixture was incubated at 37®C for 1 hour and at 4°C 
for 16 hoiurs. Incubated contents were used in the assay 
instead of serum and percent inhibition obtained at 
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TABLE 4 
Reproducibility data for anti-DNA antibody assay of positive 
SL£ sera. 
Assay Variation+S.D.® Coefficient of variation 
84.4 i 6.6 7.80 
Intra-assay 52,1 3.2 6,07 
35.0 + 1.50 4.23 
81.4 +10.1 12.41 
Inter-assay 55.0+5,2 9.45 
35.9 + 2.8 7.80 
Niimber of samples analyzed in each case is 10. 
^Standard deviation. 
fluor«scence Intensity as compared to free DHA and EB. 
The method involves the precipitation of DNA-anti-DNA complexes 
and the measurement of DNA bound to immune complexes by the 
enhanced fluorescence as a result of EB intercalation with the 
antigen• 
Apparent excitation and «nission characteristics of EB-
DNA conplexes were studied at different DNA concentrations 
Keeping EB concentration constant (5 ng/kl)» With DNA concen-
tration of 2 to 4 ng, a prominent excitation at 300 nm was 
obseirved. On increasing DNA concentration there was a shift in 
the excitation maxima from 300 to 310 nm (Fig .7;, The emission 
spectra of EB-DNA complex showed a prominent maxima at 590 nm 
(excitation 300 nm/ Fig.4;. The inset of Fig.4 shows linear 
increase in fluorescence on complex formation with increase of 
DNA concentration at 590 nm. This linear relationship was 
utilized for the quantitation of DNA in the immune complexes. 
Effect of serum proteins and ammonitsn sulfate on F.I. of 
EB-DNA complex was studied to decide the dilution of senan and 
to choose the fraction (supernatant or pellets suitable for the 
fluorescence measurements. Effect of serum proteins on F.I. of 
EB-DNA complex were studied using different dilutions of NHS. 
fThe quenching of fluorescence of EB-DNA complex was observed in 
the presence of serum proteins. The quenching was dependent on 
serxim dilution. On increasing serum dilution, fluorescence 
quenching was released. At a sertim dilution of ItS, 13 percent 
Fig. 7; Excitation spectra of EB, dsDNA and EB-DNA complex. 
Excitation spectra were recorded keeping onission 
wavelength at 590 nm. Concentration of DNA in EB-
DNA complex: 2 Mg ( ) » A fig ), 6 Mg ), 
8 Mg ( 10 lig ( - ) , free EB { -0~ ), 10 Mg of free 
DNA { ), EB concentration was kept constant (5 Mg/hilK 
60 
70 i 
> - 6 0 
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quenching was observed. Similarly the effect of ammonium sulfate 
on F,I« of EB-ONA complex was studied. At 2.9 M airanonium sulfate 
(almost 50 percent saturation) the percent quenching was 52. On 
decreasing its concentration, fluorescence quenching was released, 
but even at 0.59 M ammonium sulfate the value was 24 percent 
(Pig.SK Since both the serum proteins and ammonium sulfate were 
found to be fluorescent quenchers of EB-DNA ccwtplex, the pellet 
was chosen for the assay as the concentrations of both these 
interferring agents was quite low in the pellet as compared to 
the supernatant and the quenching effect could largely be minimized, 
NHS and sera of patients with various rheisnatic diseases 
were tested for the presence of anti-DNA antibodies (Pig.9>. 
Sera showing DNA binding activity of more than 20 percent were 
considered positive. Using this criteria, all NHS, sera of 
patients with SS and RA were negative for anti-DNA antibodies. 
Forty three percent of SLE sera were positive for anti-DNA anti-
bodies. One out of 7 SLE patients with overlapping PSS and one 
out of ten PSS patients were found to be positive for antibodies 
against DNA. 
The specificity of the assay was checked by inhibition 
experiment. Percent inhibition obtained with different DNA 
concentrations using an anti-DNA antibody positive SLE serum is 
shown in Fig.10. The antigen-antibody reaction is specific 
because of 75 percent inhibition obtained with 8 Mg of DNA, 
Fig. 8: Fluor«sc«nc« quenching of EB-DNA complex in the 
preaence of different dilutions of and varying 
concentrations of aDsnonium sulfate. 
EB-DNA conplex was prepared in varying concentra-
tions of ammonium sulfate (0.58 M to 2.9 M) and different 
dilutions of NHS (neat to i:64) as described. Fluore-
scence intensity was recorded at 590 nm (excitation 
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Pig, 9: Pravalence of anti-DNA antibodies in various rheximatic 
diseases as measured by £luorometric assay. 
The mean DNA binding values of positive SLB sera# 
NHS and other sera with standard deviations are indicated 
at the bottom of the figure. 
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Fig. 10: D«naonstration of specificity of fluorometric assay 
by inhibition experiment. 
Inhibition of antigen-antibody reaction was 
performed in the presence of varying concentrations of 
DNA (1 to 10 Mg/fnl). Other experimental details were 
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In order to compare the sensitivity of spectrophotometric 
and fluorometric techniques with those of commonly used tech-
niques (iinrounoprecipitation and h^agglutination;# various sera 
were tested for the presence of anti-DNA antibodies. These 
results (Table 5> show that both spectrophotcxnetric and fluoro-
metric methods are more sensitive than ID and CIS and almost 
parallel in sensitivity to PHA. 
s^s j^ates. 
Recently a lot of interest has been focussed in the use of 
ELISA because of simplicity and high sensitivity. ELISA was 
developed for the detection and quantitation of anti-DNA anti-
bodies in the sera of patients with SLE. The technique involves 
the adsorption of calf thymus DKA to the sxirface of microtiter 
plate and saturation of excess sites with fetal calf serum. 
After the antigen-antibody reaction, the immune complexes were 
detected by an enzymatic reaction involving alkaline phosphatase 
conjugated rabbit anti-human IgG. Measxirement of enzyme activity 
was facilitated by the use of p-nitrophenyl phosphate (PNP-P) and 
4-methyl\jmbelliferyl phosphate (4MU-P^ as siibstrates. Experiments 
were intended to ccmipare the sensitivity and reliability of the 

















« •0 •H U a •H 










Ch ^ O O O O tn r-t 
in O O O O »n iH 
«o oi o o 




9? 0* CQ (Q 
F! « i. 
Rabbit anti-human IgO-alkaline phosphatase conjugate 
purified by gel filtration on Sephadex G-200 gave an IgG-enzyme 
ratio of 4, The activity of the enzyme in conjugate was measured 
at increasing dilutions with a constant concentration of the 
sxibstrates. The reaction end point was found to be i:2560 in 
case of 4MU-P and ItSO for IWP-P providing 32 fold higher 
sensitivity in the detection of enzyme activity with the fluoro-
genic substrate (Fig.llj, Similarly when enzyme activity of the 
conjugate was measured at different substrate concentrations, 
very little of 4MU-P (1 Mg) gave a detectable reaction. The 
detectable concentration for PNP-P was 100 Mg indicating almost 
100 fold greater sensitivity with fluorogenic substrate in the 
detection of enzyme activity. The amount of antigen bound to the 
plastic surface was estimated by measuring optical density at 
260 nm after overnight incubation at 4°C and found to be about 
12% of the total antigen placed in the well. 
Detailed study of the sensitivity of the two substrates 
in ELISA was performed using serum and IgG of an SLE patient (DK) 
who had higher titer anti-DNA antibody activity. The end point 
of the reaction with PNP-P was 116400 for serum and 111600 for 
IgG, With 4MU-P as substrate the reaction titer was found to be 
1:51200 for serum and 1112800 for IgG. Fluorescence intensity 
(F.I.; and optical density (O.D.) of less than 10 and 0.1 
respectively were taken as cut off points. An 8 fold greater 
sensitivity of the reaction with fluorogenic substrate is evident, 
Pig. Ill Plot showing the ©nzyine activity as a fiinction of 
different conjugate dilutions using E«P-P and 4MU-P 
as substrates. 
0,3 ml of serially diluted conjugate (1110 to 
1:20480} was mixed with 1 ml of substrate solution 
(PNP-P, 5 X M in diethanolamine buffer or 4MU-P, 
1 X lo"^ M in AMP buffer) and incubated at 37®C for 30 
minutes. Reaction was stopped by adding 5 ml of 0,2 N 
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The sensitivity of th« two siibstrates was further compared at 
different dilutions of the conjugate using native DNA as antigen 
and at a constant concentration of purified IgG from DK (IJlOO 
at 12 mg/6nlj. The titration end point was found to be 1:40960 
for and 112560 for PNP-P. Therefore, the fluorogenic 
substrate Increased the sensitivity of the assay almost 16 times 
(Fig.l2>, The optimum concentration of the conjugate was almost 
same for both the substrates, This concentration was found to be 
43 Mg conjugate protein/lnl in our experiments. 
Fig. 13 shows the results obtained with IgG in ELISA using 
different concentrations of DNA, With PNP-P the minimum concen-
tration of antigen for a detectable reaction was 18 nM bp whereas it 
was 2 nM bp for 4MU-P. Thus the fluorogenic substrate increased 
the sensitivity of the assay 9 times. The antigen concentration 
used, for both the substrates, was 19 uM bp. On varying the 
period of incubation, a linear relationship with the amount of 
PNP fozmed upto 90 minutes was observed (Fig,14;, The reaction 
followed linearity upto 150 minutes with fluorogenic substrate. 
An inciibation time of 60 minutes was used in all our experiments. 
These characteristics of fluorogenic substrate were 
exploited in the detection and quantitation of anti-DNA antibodies 
in the sera of patients with SLE, Results were compared with the 
assay \ising PNP-P as s\ibstrate. Tables 6 and 7 show the 
characteristics of various sera tested by ELISA using PNP-P and 
4MU-P as substrates. Each serum was tested at varioxis dilutions 
Pig. 12t Comparison of the sensitivity of the two substrates 
in ELISA at different conjugate dilutions. 
Serial dilutions of the conjugate (neat to 
1181920) and a fixed concentration of DNA (19 WM bp) 
and antibody (ItlOO of serum or 12 rag/fel IgG) were 
used. The reaction product were monitored as des-
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Pig. 13t Effect of antigen concentration on the sensitivity o£ 
ELISA with the two substrates. 
The experiment was performed by coating different 
amount of DNA (1 nM bp to 23 m hp) in the wells of 
microtiter plate. ELISA was carried out with PNP-P and 
4MU-P. A i:5 dilution of the conjugate and i:iOO 
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Fig, 14; A plot of alkaline phosphatase activity in conjugate 
against incubation time in ELISA. 
The assay was carried out at an antigen concentra*-
tion of 19 ^ bp. The concentration o£ the conjugate 
and antibody were as in legend to Fig. 13. Iimnxine 
complex-conjugate adduct was incubated with PNP-P and 
4MU~P for different time intervals and the product 
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Starting from lllOO, Average 0,D, and P.I. were calculated at 
each «er\jra dilution with separate groups of normal and disease 
patients. The reaction was considered negative when O.D. and 
P,I» of the reaction product were less than 0.1 and 10 respectively 
at a seriam dilution of i:iOO. With this criteria of assay 
reaction* all normal htiman sera studied were negative for antl*-
DNA antibodies. Fifty seven percent of SLE sera were positive 
with colorlgenlc substrate and 71 percent were positive with 
fluorogenlc substrate. 
In order to compare the sensitivity of ELISA with that of 
PHA, SLE sera were checked for hemagglutlnatlng antl-DNA antibodies, 
Five 9ut of 14 sera (36 percentJ were positive by PHA. All sera 
positive by PHA were also positive with BLISA. In addition« some 
of the serum samples negative by PHA were positive by ELISA 
(Table 8 K These results indicate approximately 1.5 to 2 fold 
Increase in sensitivity* depending on the substrate* of ELISA 
over that of PHA. 
The sensitivity of ELISA can be limited by factors which 
Include the type of solid phase and method used to monitor enzyme 
activity. As mentioned earlier* an increase in the sensitivity 
of ELISA was observed by the uise of fluorogenlc substrate for the 
measurement of enayme activity. The sensitivity of ELISA has 
TABLE 8 
Comparative study of antl-DNA antibody titer of SLE sera by ELISA 
and passive hemagglutination technique. 
RO 
Sample Titer with ELISA Hemagglutination titer PNP-P 4MU-P 
DK-serum i : 6 4 0 0 1 : 5 1 2 0 0 i : i 2 8 
DK-IgG i : i 6 o o 1 : 1 2 8 0 0 1 : 3 2 
PM-serum 1 : 2 0 0 i : 8 o o 0 
BW-serum 1 : 2 0 0 i : 8 o o 1 : 2 
ST-serum 1 : 4 0 0 1 : 3 2 0 0 1 : 4 
AS-serum < 1 : 1 0 0 1 : 1 0 0 1 : 2 
SH-serum < 1 : 1 0 0 1 : 1 0 0 1 : 4 
The concentration of purified DK-IgG was adjusted to 12 mg/fel. 
Hemagglutination titer of upto lt4, fluorescence intensity units 
of less than 10 and O.D. of less than 0.10 of serum samples at 
lUOO dilution are treated as negative. Sera EW, BW, ST, AS and 
SH were negative for hemagglutinating antibody whereas, AS and SH 
were negative by ELISA with PNP-P as substrate. All sera were 
positive when was used as substrate. 
be«n fuxrther increased by the use of different solid supports 
to increase the surface area for the Immobilization of antigen. 
We developed a solid phase ELISA for the detection of antibodies 
to DNA in various rheumatic diseases employing nylon as solid 
support for antigen immobilization. The anti-DNA antibody 
incidence in various sera was compared vising fluorogenic and 
colorigenic enzyme substrates, 
Nylon beads were chosen as solid support because it 
provided greater surface area for antigen binding, ease in wash-
ing and low background values. The reaction conditions were 
established by a series of preliminary experiments tising a 
positive anti-DNA antibody SLE serum. All the sera were tested 
in triplicate and the A/P-I. values were expressed as the arith-
metic mean. 
OptiraiM time for the activation of nylon beads was studied 
by their incubation with 3,5 N HCl for different time periods. 
After each time interval the beads were washed, coated with 
antigen and used in SLISA. As shown in Pig, 15 the extinction 
values \asing a positive SLE serum increased 72 hours. 
However, 36 hours activation was routinely done as the beads 
tend to crack after longer incubation. 
Activated beads were treated with different DNA concentra-
tions (5 Mg to 400 at A°C for 24 hours, Amoxint of antigen 
coated on the beads was estimated by recording the absorbanee of 
Fig. 15t Activation of nylon b«ad8 as a function of time. 
Beads were activated for different time intervals 
(6-72 hoxirs; by incubating in 3,5 N HCl at 37°C and 
ELISA was performed with a positive antl-DNA antibody 
SLE serum. 
8 SL 
TIME OF ACTIVATION (HOURS) 
O 
the residual solution at 260 nm. It appears that at 100 m^ of 
DNA* maxlmtro antigen gets coated on the beads (Table 9JI, when 
antigen coating was compared at 37°C and at for different 
time periods, maximum coating was obtained at 4®C for 24 hoxirs, 
The effect of pH variation on antigen coating was studied 
by performing the coating with antigen prepared in Mcllvaine 
(pH 3 to e; and carbonate (pH 9 to 10) buffers. The coated 
beads were processed for ELISA as described using an antibody 
positive SLE semm. The coating was pH dependent (Fig.16) with 
a maxima at pH 5. 
ELISA was performed with varying nianber of antigen coated 
beads (1-10) to optimize the number of beads to be used in the 
experiment, six beads were chosen since maximtjm absorbance 
values were obtained using this number (Pig.17). Coefficient of 
variation of 20 different sets of six beads with an anti-DNA 
antibody positive SI«E serum was around 10 percent. 
The specificity of antigen antibody reaction in ELISA was 
cheeked by inhibition e3q;>erlments. Varying concentrations of 
DNA were mixed with an anti-I»?A antibody positive SLE aerxm to 
a final concentration of 2 to 20 Aig DNA/INL. The mixture waoi 
Incubated at 37®C for 1 hour and then at 4°C for 20 hours and 
used in ELISA Instead of serum. Percent inhibition obtained at 
different DNA concentrations is shown in Fig. 18. It Is evident 
that the reaction is specific because of high Inhibition (53%) 
with only 4 Mg of DNA. 
p « 
TABLE 9 
UptaX® of DNA by nylon beads 
DNA concentration Uptake of DNA per bead 








The concentration of antigen was varied between 5 Mg 
to 400 Mg/nl and antigen uptake was estimated by 
checking the residual DNA In the supernatant at the 
end of Incubation by recording the absorbance at 
260 nm. 
Fig. 16: Effect of pH on antigen coating. 
Activated beads were coated with DNA (100 Mg/fnl) 
in Mcllvaine 3 to 8) and carbonate (pH 9 to 10) 
buffers at 4®C for 24 hours. Antigen coated beads were 
processed for ELISA using a positive SLE serum. 
PH 
Fig, 17: ELISA with varying number of antigen coated beads. 
Increasing number of DNA coated beads (1 to 10) 
were used in ELISA. Other experimental details are as 
described in Methods. 
H» 
NUMBER OF BEADS 
Fig. is: Inhibition ELISA for anti-DNA antibodies. 
Varying concentrations of DNA (2 to 20 Mg/tnl) 
were mixed with a positive anti-DNA antibody SLE serum 
(1:100; and incubated at 37°C for 1 hour and at 4°C 
for 20 hours. Incubated contents were used in ELISA 
instead of serum. 










Effect of storage of antigen coated beads on the anti-
genicity was studied, ELISA was performed with antigen coated 
beads, stored dry at -20®C for different weeks. The results 
obtained show that ELISA can conveniently be performed with beads 
stored upto 4 weeks without any appreciable loss in the antigeni-
city. Decrease in the absorbance values is observed, if the 
beads are not stored dry. 
Normal human sera and sera of patients with rheumatic 
diseases (SLE, SLE + PSS, PSS, SS, RAi were tested for the 
presence of anti-DNA antibodies by ELISA using colorigenic and 
fluorogenic enzyme substrates. Sera showing P.I/A of more than 
12/t),12 were considered positive. Using this criteria all normal 
human sera and sera of patients with RA, SS were negative for 
anti-DNA antibodies. Fifty two and 56 percent of SLE sera were 
positive for antibodies to DNA by PNP-P and 4MU-P respectively, 
Povirteen percent of SLE patients with overlapping PSS and 10 
percent of PSS patients showed a positive antibody profile with 
both the substrates (Figs,19 and 20). 
The assay described can easily be miniaturized in condi-
tions where small amounts of reagents (antigen or antibody J are 
available. We have successfully decreased the volume of reagents 
(0,1 ml instead of 0,5 ml J and used 2 beads for the measurement 
of anti-DNA antibodies in those conditions where very low serum 
samples were available for screening. 
Fig, 19! Incidence o£ antl-DNA antibodies In rhetimatlc diseases 
by ELISA with nylon as solid phase, using niP-P as 
enzyme substrate. 
NHS and sera of patients with SLE, SLE + PSS, PSS, 
SS and RA were tested for the presence of antl-DNA anti-
bodies using PNP-P as substrate. The mean absorbance 
values with standard deviations are Indicated at the 
bottom of the figure. 
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Fig. 20: Incidence of anti-DMA antibodies in rheumatic diseases 
by ELISA with nylon as solid phase, using 4MU-P as 
enzyme substrate. 
ELISA was pez^ozmed with 4MU«-P as siibstrate. 
Other details are given in legend to Pig, 19. 
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SLE sera and sera of patients with PSS, SLE + PSS, SS and 
RA were tested by ID, CIE, PHA and ELISA with nylon beads using 
4MU-P as enzyme substrate, for the presence of anti-DNA antibo-
dies , On the basis of the antibody level, these sera were arbi-
trarily- classified into three major groups. 
I. Sera with high avidity anti-DNA antibodies (F.I. > 25) — 
detectable by ID, CIE, PHA and ELISA. 
II. Sera with moderate avidity anti-DNA antibodies <P.I. 
between 15 and 25) — detectable by PHA and ELISA. 
III. Sera with low avidity anti-DNA antibodies (F.I. between 
12 and 15; — detectable only by ELISA. 
On the basis of above classification 13 percent of SLE 
patients belonged to group I, 23 percent of SLE patients and 14 
percent SLE -f PSS patients to group II and 21 percent SLE 
patients, 14 percent SLE -i- PSS and 10 percent PSS patients to 
group III (Table 10), 
(7) Exgerimentallx^induced^an^ 
Before aliciting anti-DNA-psoralen antibodies, the extent 
of cross-linXing between DNA and psoralen was evaluated by 
ti t^ 
TABLE 10 
Determination of low, moderate and high avidity anti-raiA antibodies 
by various techniques, 
Sera ID, PHA and ELISA F.I. > 25 (High avidity) 
Percent sera detectable by 
PHA and ELISA F.I. between 15 and 25 (Moderate avidity) 
ELISA F.I. between 12 and 15 (Low avidity; 
SLE 



















Anti-DNA antibodies in rheumatic diseases were arbitrarily 
classified into 3 broad groups on the basis of results obtained 
by ID, CIE, PHA and ELISA using nylon as solid support. 
studying the spontaneous renaturation capacity of cross-linked 
DNA by means of column chrcmatography. The separation of renatiired 
fractions from irreversibly denatured DNA was performed by colunm 
chromatography on hydroxyapatite, DNA-psoralen photoadduct after 
denaturation was eluted at 0.25 M phosphate buffer, pH 7.2 almost 
similar to that of native DNA indicating cross-linking between 
the two. Sample of ONA and psoralen without irradiation was the 
experimental control which was eluted at 0.2 M phosphate buffer, 
pH 7.2 similar to that of denatured DNA (Fig.21). 
The s^ ioxint of psoralen intercalated with DNA was deter-
mined by equilibritim dialysis measurements. The amount of 
psoralen dialyzed out was guantitated with the help of standard 
plot obtained by drawing P.I. of irradiated psoralen as a function 
of its concentration. The binding ratio of 1;JJM psoralen per 56 
tm bp of DNA has been found by eguilibrivim dialysis. 
Antibodies to DNA-psoralen adduct, dsDNA, ssDNA and RNA 
in the sera of guinea pigs immunized with DNA-psoralen adduct 
were studied by EX.XSA, innnunoprecipitation and hemagglutination 
techniques. No reactivity was observed with any of the antigen 
by ID, CIE, PHA. Immunized sera showed a positive reaction in 
ELISA on nylon with DNA-psoralen adduct and dsDNA whereas ssDNA 
and RNA exhibited low reactivity with the immunized sera 
(Table IIK 
Pig, 21; Hydroxyapatite chromatography of DNA-psoralen adduct 
after denatiaration, 
The covalent photoadduct was heat denatured, fast 
cooled and then passed through a hydroxyapatite colunurx 
(5.5 an x 1,5 cm). The contents were eluted with 0.20 
and 0.25 M phosphate buffer« pH 7.2, Sample of DNA and 
psoralen without irradiation was the experimental 
control and v>as eluted at 0.2 M phosphate buffer, pH 
7.2 (-•-), The fraction eluted at 0.25 M phosphate 
buffer, pH 7.2 was taken as DNA-psoralen adduct 
and used as antigen. 
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DK was an SLE patlant with a serum titer o£ i:51200 by 
ELISA using 4MU->P as enzyme substrate. The serum was positive 
for precipitating and hemagglutinating anti-DNA antibodies by 
ID, CIE and PHA, CIE of the serum revealed precipitin lines with 
dsDNA, ssDNA, buffalo thymus RNA, E, coli RNA and DNA-psoralen 
adduct as antigens. Faint precipitin reactionswere observed with 
yeast RNA and purified Sm/RNP antigens. IgG isolated frcwi this 
servttn by DEAE-cellulose chrcsnatography gave identical lines with 
these antigens showing complete reaction of identity with serum 
lines. When affinity purified anti-DNA antibodies were used in 
CIE« a stJTong line was seen with dsDNA but no other lines were 
observed with any of the antigen indicating the specificity of 
antl-dsDNA antibody. Similar results were obtained by ID. 
The specificity and reactivity of affinity purified 
material at different concentrations varying from 0.06 jyig/tnl to 
120 M9/inl was also checHed by ELISA utilieing dsDNA, ssDKA, DNA-
psoralen adduct and RNA coated beads. The results obtained are 
tabulated in Table 12, These antibodies were found to be highly 
specific for double-stranded DNA and exhibited strong reactivity 
with DNA-psoralen adduct. Very poor reactivity was observed with 
ssDNA and buffalo thymus SNA. 
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serum (DKj, anti-DHA antibodittS were Isolated by affinity 
chromatography tising dsDNA-linked Sepharose 4B column. EltiSA 
was carried out with different antibody concentrations varying 
from 0.06 Mg/fnl to 120 Mg/inl, using dsDNA coated beads. Immune 
complex attached to nylon beads was detected by enzymatic 
reaction involving alkaline i^osphatase conjugated goat anti-
human IgQ and I ^ . The results obtained are shown in Fig. 22. 
IgG and ratio in the purified antibody preparation was 511, 
Fig. 22: Determination of IgG/IgM ratio in the affinity 
purified antibodies by BLISA, 
ELISA was performed with varying antibody 
concentrations (0,06 Mg/inl - 120 ng/ial) «nploying 
dsDNA coated beads. Goat anti-human IgG (-0- ) and 
( } alkaline phosphatase conjugates at dilutions 
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The pathogenic significance of anti-DNA antibodies has 
been well documented in SLE and the antibody levels are claimed 
to correlate well with disease activity (Swaak et al., 1979J. 
However, the qualitative and quantitative evaluation of anti-DNA 
antibodies is still being investigated for the perfection as 
reflected by the nuiriDer of different methods that have been 
developed for their measurements. Radioimmtinoassay (RIA^ has 
been extensively vuied for the detection of anti-DNA antibodies 
(Talal and Pillarisetty, 1976;, Sophisticated radioactive 
measuring instruments limit its use in laboratories where all 
these facilities are not available. These problems emphasize 
the need for a new simplified approach to measvire anti-DNA 
antibodies. 
The results obtained by spectrophotc»netric and fluoronetric 
techniques are clearly indicative of their greater sensitivity 
than ID and CIE and ccxnparability with PHA. Both the assays 
could therefore be «nployed for the detection of low affinity 
antibodies produced by immunized animals and SLE patients having 
low circulating concentrations of anti-DNA antibodies. Such 
antibodies practically act as univalent antibody and are not able 
to form stable precipitating complexes with antigen (Marghi et gl,., 
1980; . The reason for low incidence of anti-DNA antibodies by 
iawunoprecipitation has not been established. Avidity, restricted 
K ; 
httt«rogen«lty and the formation of soluble complexes are known 
factors which may effect the precipitin reaction. 
High binding values were observed in normal human sera 
with dsONA by spectrophotometric assay. The DNA binding of 
almost the same extent has been reported by other methods of 
measurements. This could be due to either low level of anti-DNA 
antibodies in normal human sxabjects or the nonspecific association 
of proteins and other materials found in serxim with polyanionic 
DNA. Moreover« antibodies to nucleic acids have been found 
increased in aged healthy individuals (Schuller et al.« 1981) 
which can further contribute to increased binding observed in 
apparently normal individuals. Both spectrophotometric and 
fluorometric methods described here are simple, specific, repro-
ducible and suitable for use in clinical laboratories where 
facilities for radioimmunoassay do not exist. 
SLE sertBD contain heterogeneous population of anti-DNA 
antibodies with varying degree of avidity. Some authors have 
reported that in humans circulating antibodies with high avidity 
for DNA are more likely to be associated with severe active 
disease and nephritis (Leon et §1., 1977). Others have correlated 
low affinity circulating antibody with severe nephritis (Asano 
and Nakamoto, 1978). In mice, low avidity antibodies in the 
circulation appear at the time nephritis begins (Steward et gl., 
1975). Differences between avidity studies may reflect (i) differ-
ent methods employed for the detection of anti-DNA antibodies 
It. 2 
(11) difficulty in calculating avidity with a bivalent antibody 
and a large relatively undefined DNA substrate and (ill) antibody 
heterogeneity (Hahn, 1982K In recent years^ Parr assay and 
Millipore filterassays are under criticisra for alleged inability 
to detect low avidity anti-DNA antibodies (Rxibbin et al., 1978), 
Smeenk et al, (1982) reported the detection of low avidity anti-
bodies in SLE serisn by high sensitivity polyethylene glycol 
precipitation assay# not detected by conventional techniques. 
Recently much interest has been directed in the use of 
ELISA in view of its operational simplicity and high sensitivity 
(Hendry and Herrmann, 1980,* Aitkaci et al.* 1981; Goodbum et al., 
1981). Antibodies against native DNA have been evaluated by 
ELISA using glucose oxidase labelled antibodies (Labrouce et al., 
1980), Their results were similar with those of Farr assay. 
ELISA has also been developed and evaluated for the detection of 
antibodies to DNA in experimental animals (Hillyer and Modeline, 
1980). Recently ELISA for the measur«tiient of anti-DNA levels 
has been reported (Kaval fS 1982) using horse radish 
peroxidase-linked IgG, IgM and IgA conjugates. The substrate 
for monitoring the enzyme activity has generally been PNP-P 
(Voller et al., 1976,* Harris et al., 1979). 
In order to increase the sensitivity of ELISA, the con-
ventional n^P-P has been replaced by a fluorescent sxibstrate 
4MU-P (Shalev et al., 1980). We adopted ELISA for the detection 
I f S-J 
«nd quantitation of anti-iaiA antibodies xxsing both PNP-P and 
as anzyme substratas. In tha present study a 100 times 
lower concentration of the product (4MUJ was detected by 
fluorometry in relation to PNP. This is not in full agre«nent 
with that of 1000 fold increased sensitivity of the fluorogenic 
substrate reported earlier (Shalev et al., 1980J. This differ-
ence could possibly be accounted on the basis of different 
source of alkaline phosphatase used for preparing the conjugate 
resulting in lower specific activity. At different dilutions of 
antigen or antibody 9 times greater sensitivity was observed 
with fluorogenic substrate. However, at different conjugate 
dilutions the sensitivity of the assay was 16 fold higher with 
4MU-P and are in full agrement to those reported by Shalev et 
j|l. (1980), We found an incidence of 57% of circulating DNA 
antibodies in SLE patients by ELXSA with colorigenic and 71% 
positive with fluorogenic substrate. These results are clearly 
indicative of the greater sensitivity of fluorogenic substrate 
and could therefore be employed for the detection of low avidity 
antibodies. The same serum samples when tested by passive 
hemagglutination techniqfue have an incidence of 36% for DNA 
antibodies. Some of the sera negative by PHA showed a strong 
positive reaction with ELISA. An agglutination inhibiting factor 
has been reported in thyrotoxic serum (Wilkin et fl., 1979). It 
is possible that a similar factor is also present in some SLE 
sera inhibiting agglutination. The absence of hemagglutinating 
I '••f 
•ntlbodl«s in thttse sera could possibly be another contributory 
factor for low incidence. 
We report the successful utilization of nylon as solid 
support for binding of DKA for use in ELI6A in the detection of 
anti-DNA antibodies. High backgrotmd noise poses major limita-
tions in the success of enzyme iiranunoassays, Our experiments 
indicate that background activity can considerably be reduced by 
introducing nylon as solid support instead of conventional 
polystyrene surface. High back-ground values obtained due to 
nonspecific binding of the conjugate onto the walls of the test 
tube^ have been reduced substantially in the present method by 
introducing last washing with distilled water and carrying out 
the enzymatic reaction with dried beads in separate tubes. ELISA 
in conjxinction with nylon as solid support ccanbines the advantages 
of (i^  the high sensitivity obtained by the use of fluorogenic 
enzyme substrate (ii; low background values and (iii} facility for 
prolonged storage of antigen coated solid phase^ making the assay 
highly sensitive, specific and economical. The ability of DNA 
coated nylon beads to retain antigenicity for a considerable 
period of time is of special importance since the cumbersome 
daily antigen coating procedure is avoided. The method is simple 
and could be conveniently «anployed for the detection of low 
avidity anti-DNA antibodies which were not detectable by commonly 
used techniques. It may allow an earlier diagnosis of the disease 
which might be helpful in the management of patients. The 
po»»ibillty of distinguishing between different disease patterns 
is also feasible. Moreover^ in the miniaturized form the method 
has scope in conditions where very small amounts of patients sera 
are available for assay. 
The high incidence of anti-dsDNA antibodies detectable 
in patients with inactive SLE suggests that ELISA is potentially 
useful for diagnostic screening of asymptomatic individuals and 
patients with syndromes suggestive of SLE. The sensitivity of 
ELISA is comparable with that of radioinmxmoassay and avoids the 
Known dangers of isotope work. The ELISA test circumvents 
several problems inherent to radioimmiaioassay procedure. Mole-
cular weight of antigen does not influence the reaction of anti-
bodies with DNA insaobilized on solid phase. On contrary, in RIA 
7 
only DNA molecules of molecular weight of 1x10 daltons or less 
are precipitated by a single antibody molecule^ and therefore 
high molecular weight DNA requires a molar antibody-antigen ratio 
of greater than (»ie for precipitation by amnonium sulfate (Aarden 
et fi., 197Cb;. Antibody binding avidity is another factor which 
may account for differences between ELISA and RIA. ELISA directly 
measures ganona globulins thereby excluding interference by 
nonimmunoglobulin interactions with DMA such as Clq globulin and 
DNA binding proteins. In addition, the test system may be used 
to assay a variety of properties of the antibody like immuno-
globulin class, compleMent fixing property and relative avidity. 
The ability to objectively quantitate antibody as well as the 
potential for automation indicates that the solid phase imnuno-
assay is potentially a useful procedure for the study of the 
variety of antibodies occurring in the sera of patients with SLE, 
Intramuscular injections of dsDNA and ssDNA complexed 
with MBSA elicited antibodies against ssDNA in immunized rabbits 
as detected by immunoprecipitation and hemagglutination techniques . 
The comparison of immxinological behaviour of DNA antibodies of 
% 
SLE sera and sera of immunized animals demonstrated the difference 
in specificities of the two types of antibodies. Experimentally 
induced antibodies reacted with ssDNA but not with dsDNA indica-
ting their specificity for bases and that the antigenic determi-
nants are not related to the back bone of nucleic acid. Earlier 
studies in rabbits suggested that nucleic acids were haptens 
(Plescia and Braun, 1967 J• Later work clearly demonstrated 
that antibodies to double-stranded DNA could not be induced 
whereas antibodies to double-stranded RNA, synthetic double-
stranded DNA« single-stranded DNA, oligonucleotides« nucleotides, 
nucleosides and bases could easily be elicited (Stollar and o 
Ward, 1970i. Anti-ss DNA appears frequently in diseases other 
than lupus (Bell e^ §1,, 1975K These antibodies are frequently 
induced inadvertently in humans, without appearance of anti-
native DNA antibodies, dtiring treatment with procainamide and 
certain other drugs which are known to induce antinuclear anti-
bodies. Many drugs have been implicated in the pathogenesis of 
SLE-related syndromes which include procainamide, hydralazine. 
sulfonamides, Isoniazld, trlraethadione, phenylbutazone, strepto-
mycin, tetracycline and griseofulvin (Blomgren et al,, 1972J. 
It has been suggested that these drugs with the ability to fona 
complexes with DNA and DNA-protein are most likely to induce 
antinuclear antibody formation (Grabar, 1974;. Recently anti-
nuclear antibodies have been reported in psoriatic patients 
undergoing photocheraotherapy. Antibodies to dsDNA have not been 
detected although, it is hnown that psoralen forms a covalent 
photoadduct with DNA in the presence of UV light and makes its 
immunogenic (Zarebska et al,, 1978K In these studies Parr assay 
was employed for the detection of such antibodies which has been 
shown to be unable to detect low avidity anti-DNA antibodies. 
BLISA on nylon as solid support has been successfully 
utilized for the detection of antibodies against DNA, RNA, ssDNA 
and DNA-psoralen adduct in animals immunized with DNA-psoralen 
adduct. We report that on intercalation with psoralen in the 
presence of UV-A light, DNA becomes immunogenic and antibodies 
formed have reactivity against DNA-psoralen adduct and dsDNA. 
These antibodies showed poor crossreactivity with ssDNA and RNA 
indicating that the antibodies probably are conformational 
directed. Our results show that although it is not possible to 
immxinize animals against dsDNA but when DNA is intercalated with 
psoralen, this apparently nonimmunogenic molecule beccxne immuno-
genic. This might be as a result of some structural changes in 
the molecule induced by intercalation with psoralen. The low 
fiQ I' 'J 
reactivity of IrranuniB^ d sera with »«DNA and RNA could probably 
to* due to nonavilability o£ the antigenic bases to elicit antibody 
response resulting in the failxire of the appearence of anti-ssDMA 
specific antibodies. 
SLE anti-DNA antibodies Isolated by affinity chromato-
graphy using dsDNA-Sepharose 4B columns were used to study the 
specificity of immune sera. SLE antibodies reacted specifically 
with dsONA and showed strong reactivity with DNA-psoralen adduct 
while single-stranded DHA and RNA exhibited low reactivity. The 
antigenic specificity of these antibodies was indistinguishable 
from antibodies raised by immuniaation of animals with DNA-
psoralen adduct as is clear from the results obtained in ELISA. 
The specific etiological factors that cause SLE have 
eluded identification to the present time with the exception of 
patients who have a lupus like syndrome in relation to exposxure 
to certain drugs (Hess, 1982). Genetic, viral, hormonal and 
environmental factors are all probably involved in the patho-
genesis of this disease providing evidence for a truely multi-
factorial etiology. In drug induced lupus it has been suggested 
that these agents interact with DNA-protein complex in vivo and 
the resulting interaction renders it immunogenic and result in 
the production of autoantibodies. The formation of covalent 
steroid-protein adducts on incxibation of albumin with Cortisol 
or 16 a-hydroxyestrohe and its possible involv«nent in the patho-
fsD 
genesis of SLE has recently been attonpted (Bucala et 5I,,1982). 
On the basis of our observation that covalent DNA-psoralen ad<auc± 
elicit anti-DNA antibodies in experim«ital animals, it could be 
assumed that similar structiiral changes in DNA by interaction 
with above mentioned a g e n t m i g h t render it highly antigenic 
in susceptible individuals initiating and contributing to the 
pathogenesis of SLE. 
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